<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:43.7pt;left:56.0pt;line-height:14.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:14.0pt">Special Article</span></p>
<p style="top:70.4pt;left:56.0pt;line-height:18.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:18.0pt">Impact of high iron intake on cognition and neurodegeneration</span></p>
<p style="top:90.4pt;left:56.0pt;line-height:18.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:18.0pt">in humans and in animal models: a systematic review</span></p>
<p style="top:121.1pt;left:56.0pt;line-height:12.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:12.0pt">Sonal Agrawal, Kiersten L. Berggren, Eileen Marks, and Jonathan H. Fox</span></p>
<p style="top:152.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt">Context:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt"> Accumulation of brain iron is linked to aging and protein-misfolding</span></p>
<p style="top:165.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">neurodegenerative diseases. High iron intake may influence important brain health</span></p>
<p style="top:178.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">outcomes in later life.</span><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt"> Objective:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt"> The aim of this systematic review was to examine</span></p>
<p style="top:191.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">evidence from animal and human studies of the effects of high iron intake or pe-</span></p>
<p style="top:204.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">ripheral iron status on adult cognition, brain aging, and neurodegeneration.</span><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt"> Data</span></p>
<p style="top:217.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt">Sources:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt"> MEDLINE, Scopus, CAB Abstracts, the Cochrane Central Register of Clinical</span></p>
<p style="top:230.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">Trials, and OpenGrey databases were searched.</span><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt"> Study Selection:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt"> Studies investi-</span></p>
<p style="top:243.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">gating the effect of elevated iron intake at all postnatal life stages in mammalian</span></p>
<p style="top:256.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">models and humans on measures of adult brain health were included.</span><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt"> Data</span></p>
<p style="top:269.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt">Extraction:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt"> Data were extracted and evaluated by two authors independently,</span></p>
<p style="top:282.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">with discrepancies resolved by discussion. Neurodegenerative disease diagnosis</span></p>
<p style="top:295.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">and/or behavioral/cognitive, biochemical, and brain morphologic findings were</span></p>
<p style="top:308.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">used to study the effects of iron intake or peripheral iron status on brain health.</span></p>
<p style="top:321.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">Risk of bias was assessed for animal and human studies. PRISMA guidelines for re-</span></p>
<p style="top:334.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">porting systematic reviews were followed.</span><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt"> Results:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt"> Thirty-four preclinical and 14</span></p>
<p style="top:347.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">clinical studies were identified from database searches. Thirty-three preclinical stud-</span></p>
<p style="top:360.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">ies provided evidence supporting an adverse effect of nutritionally relevant high</span></p>
<p style="top:373.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">iron intake in neonates on brain-health-related outcomes in adults. Human studies</span></p>
<p style="top:386.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">varied considerably in design, quality, and findings; none investigated the effects</span></p>
<p style="top:399.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">of high iron intake in neonates/infants.</span><span style="font-family:AdvOT898e3fb7.BI,serif;font-size:11.0pt"> Conclusions:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt"> Human studies are needed to</span></p>
<p style="top:412.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">verify whether dietary iron intake levels used in neonates/infants to prevent iron de-</span></p>
<p style="top:425.1pt;left:128.0pt;line-height:11.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:11.0pt">ficiency have effects on brain aging and neurodegenerative disease outcomes.</span></p>
<p style="top:482.2pt;left:137.3pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">INTRODUCTION</span></p>
<p style="top:506.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Iron proteins have key roles in normal brain function</span></p>
<p style="top:518.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and the processes of brain development, including neu-</span></p>
<p style="top:531.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">rogenesis, myelination, synaptic development, and en-</span></p>
<p style="top:543.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ergy and neurotransmitter metabolism.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">1</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">3</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The large</span></p>
<p style="top:556.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">amount of iron required to perform these functions is</span></p>
<p style="top:481.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">acquired from blood, mainly during periods of rapid</span></p>
<p style="top:493.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">brain growth.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">4</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">In adult life, iron uptake by the brain still</span></p>
<p style="top:506.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">occurs, though at levels significantly lower than those</span></p>
<p style="top:518.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">during development.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">5</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Iron levels in the brain can be al-</span></p>
<p style="top:531.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tered by peripheral iron levels and iron nutrition.</span></p>
<p style="top:543.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Effects of iron nutrition on the brain have been studied</span></p>
<p style="top:556.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">extensively in iron deficiency, the leading nutrient</span></p>
<p style="top:584.7pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Affiliation:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt"> S. Agrawal</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> and</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt"> J.H. Fox</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> are with the Department of Veterinary Sciences, University of Wyoming, Laramie, Wyoming, USA.</span></p>
<p style="top:595.2pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">K.L. Berggren</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> is with the Department of Radiation Oncology, University of New Mexico Cancer Center, Albuquerque, New Mexico, USA.</span></p>
<p style="top:605.7pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">E. Marks</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> is with the Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.</span></p>
<p style="top:621.8pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Correspondence:</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt"> J.H. Fox</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, Department of Veterinary Sciences, University of Wyoming, 1174 Snowy Range Rd, Laramie, WY 82070, USA.</span></p>
<p style="top:632.3pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Email: jfox7@uwyo.edu. Phone:</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfe;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">1-307-766-9953.</span></p>
<p style="top:648.5pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">Key words: brain aging, iron nutrition, iron supplementation, protein-misfolding neurodegenerative diseases.</span></p>
<p style="top:665.1pt;left:55.6pt;line-height:7.8pt"><span style="font-family:AdvP80516,serif;font-size:7.8pt">V</span></p>
<p style="top:666.4pt;left:57.0pt;line-height:5.2pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:5.2pt">C</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> The Author(s) 2017. Published by Oxford University Press on behalf of the International Life Sciences Institute.</span></p>
<p style="top:675.0pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://</span></p>
<p style="top:685.6pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium,</span></p>
<p style="top:696.1pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">provided the original work is not altered or transformed in any way, and that the work properly cited. For commercial re-use, please con-</span></p>
<p style="top:706.6pt;left:56.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tact journals.permissions@oup.com.</span></p>
<p style="top:726.0pt;left:446.6pt;line-height:8.5pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:8.5pt">doi: 10.1093/nutrit/nux015</span></p>
<p style="top:737.1pt;left:56.0pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">456</span></p>
<p style="top:737.1pt;left:413.2pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:469.4pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:44.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">deficiency worldwide.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">6</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Iron deficiency during both de-</span></p>
<p style="top:57.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">velopment and adulthood results in diverse effects on</span></p>
<p style="top:69.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neural function.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">7</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">9</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">In contrast, the effects of high pe-</span></p>
<p style="top:82.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ripheral iron status on the brain are poorly understood.</span></p>
<p style="top:94.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The widespread use of iron-fortified foods, such as milk</span></p>
<p style="top:107.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">replacers, other beverages, and solid foods, as well as</span></p>
<p style="top:119.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron supplements has decreased the prevalence of defi-</span></p>
<p style="top:132.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ciency in all age groups in many populations. However,</span></p>
<p style="top:144.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron-augmented diets also have the potential to increase</span></p>
<p style="top:157.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron intake above levels needed to prevent deficiency.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">10</span></sup></p>
<p style="top:169.9pt;left:78.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Brain aging and protein-misfolding neurodegenera-</span></p>
<p style="top:182.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tive diseases such as Alzheimer disease, Parkinson disease,</span></p>
<p style="top:194.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Huntington disease, and amyotrophic lateral sclerosis</span></p>
<p style="top:207.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">share some common mechanisms.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">11</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Older age is the</span></p>
<p style="top:219.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">greatest risk factor for the accumulation of misfolded pro-</span></p>
<p style="top:232.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">teins that typifies the earliest stages of Alzheimer disease</span></p>
<p style="top:244.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and Parkinson disease.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">12</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Therefore, Alzheimer disease and</span></p>
<p style="top:257.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Parkinson disease may represent pathologic extensions of</span></p>
<p style="top:269.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">normal processes of brain aging. Protein misfolding, pro-</span></p>
<p style="top:282.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tein accumulation, and neurodegeneration are also core</span></p>
<p style="top:294.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">features of Huntington disease and amyotrophic lateral</span></p>
<p style="top:307.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">sclerosis.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">13</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">14</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Accumulation of iron in the brain occurs</span></p>
<p style="top:319.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">with human aging, and iron levels correlate with cognitive</span></p>
<p style="top:332.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">function.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">15</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">16</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Iron accumulation in the brain also occurs</span></p>
<p style="top:344.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">with Alzheimer disease, Parkinson disease, Huntington</span></p>
<p style="top:357.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">disease, and amyotrophic lateral sclerosis.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">17</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">20</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Alzheimer</span></p>
<p style="top:369.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">disease, Parkinson disease, and amyotrophic lateral sclero-</span></p>
<p style="top:382.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">sis most commonly manifest as sporadic diseases.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">11</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">They</span></p>
<p style="top:394.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">are modeled in mice by mimicking the less-common ge-</span></p>
<p style="top:407.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">netic forms of the human disease and/or by using toxi-</span></p>
<p style="top:419.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">cants.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">21</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">23</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Huntington disease is caused by a single gene,</span></p>
<p style="top:432.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and several genetic mouse models exist.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">24</span></sup></p>
<p style="top:444.9pt;left:78.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">There is evidence from human and animal studies</span></p>
<p style="top:457.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">that iron dysregulation is one factor that contributes to</span></p>
<p style="top:469.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the neurodegeneration associated with Alzheimer dis-</span></p>
<p style="top:482.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ease, Parkinson disease, Huntington disease, and amyo-</span></p>
<p style="top:494.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">trophic lateral sclerosis.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">25</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">In health, iron homeostatic</span></p>
<p style="top:507.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">mechanisms maintain not only appropriate iron ab-</span></p>
<p style="top:519.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">sorption and tissue levels but also cellular and subcellu-</span></p>
<p style="top:532.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">lar location and molecular associations. Dysregulation</span></p>
<p style="top:544.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of these processes results in increased production of re-</span></p>
<p style="top:557.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">active oxygen species, resulting in molecular damage,</span></p>
<p style="top:569.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">mitochondrial dysfunction, and cell death.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">26</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Despite ev-</span></p>
<p style="top:582.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">idence of a contributory role of iron in brain aging and</span></p>
<p style="top:594.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neurodegeneration, the role of elevated iron intake as a</span></p>
<p style="top:607.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">modifier of these processes is poorly understood.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">15</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">20</span></sup></p>
<p style="top:619.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Given the increasing life expectancy and the resulting</span></p>
<p style="top:632.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">increased prevalence of neurodegenerative diseases,</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">11</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">it</span></p>
<p style="top:644.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">is particularly important to understand the effects of</span></p>
<p style="top:657.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">high iron intake at various life stages on brain aging.</span></p>
<p style="top:669.9pt;left:78.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Recommended Dietary Allowances for iron have</span></p>
<p style="top:682.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">been developed to prevent iron deficiency, and upper lim-</span></p>
<p style="top:694.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">its were established to avoid short-term adverse effects.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">27</span></sup></p>
<p style="top:707.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Possible effects of long-term iron intake above the</span></p>
<p style="top:44.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Recommended Dietary Allowance on cognition, brain ag-</span></p>
<p style="top:57.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ing, and neurodegenerative processes are not understood.</span></p>
<p style="top:69.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Furthermore, there is evidence that some populations are</span></p>
<p style="top:82.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron replete and have elevated iron stores.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">28</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The aim of</span></p>
<p style="top:94.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">this study was to use the methods of systematic review to</span></p>
<p style="top:107.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">investigate the effects of high iron intake or high periph-</span></p>
<p style="top:119.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">eral iron status on adult cognition and outcomes of</span></p>
<p style="top:132.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">protein-misfolding neurodegenerative diseases in both an-</span></p>
<p style="top:144.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">imal models and humans. The findings support a role of</span></p>
<p style="top:157.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">high iron intake as a negative modifier of brain health in</span></p>
<p style="top:169.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">adults. They also highlight gaps in understanding both the</span></p>
<p style="top:182.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">mechanisms involved and the translatability of findings in</span></p>
<p style="top:194.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">animal models to humans.</span></p>
<p style="top:221.0pt;left:403.5pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">METHODS</span></p>
<p style="top:246.0pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Review protocol</span></p>
<p style="top:270.1pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The systematic review was undertaken in accordance with</span></p>
<p style="top:282.6pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">PRISMA (Preferred Reporting Items for Systematic re-</span></p>
<p style="top:295.1pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">views and Meta-Analyses) guidelines.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">29</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">A checklist ensur-</span></p>
<p style="top:307.6pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ing adherence to PRISMA guidelines is shown in Table S1</span></p>
<p style="top:320.1pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">in the Supporting Information online. A written protocol</span></p>
<p style="top:332.6pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">was not used.</span></p>
<p style="top:358.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Information sources</span></p>
<p style="top:382.5pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The following electronic databases were searched:</span></p>
<p style="top:395.0pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">MEDLINE, Scopus, CAB Abstracts, the Cochrane</span></p>
<p style="top:407.5pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Central Register of Clinical Trials, and OpenGrey. A</span></p>
<p style="top:420.0pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">computerized literature search was conducted to iden-</span></p>
<p style="top:432.5pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tify studies that had been published up to June 28, 2016.</span></p>
<p style="top:445.0pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Search strategies are shown in Appendix S1 in the</span></p>
<p style="top:457.5pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Supporting Information online.</span></p>
<p style="top:483.3pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Study eligibility criteria</span></p>
<p style="top:507.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Study inclusion and exclusion criteria and research</span></p>
<p style="top:519.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">questions were developed using the PICOS (population,</span></p>
<p style="top:532.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">intervention,</span></p>
<p style="top:532.4pt;left:371.3pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">comparators,</span></p>
<p style="top:532.4pt;left:432.6pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">outcome,</span></p>
<p style="top:532.4pt;left:478.3pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">study</span></p>
<p style="top:532.4pt;left:508.3pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">design)</span></p>
<p style="top:544.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">model. Included were studies investigating the effect of</span></p>
<p style="top:557.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">elevated iron intake at all postnatal life stages in mam-</span></p>
<p style="top:569.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">malian models and humans on measures of adult brain</span></p>
<p style="top:582.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">health. Neurologic status in animal models is evaluated</span></p>
<p style="top:594.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">using a number of outcomes that include cognitive test-</span></p>
<p style="top:607.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ing; biochemical measurement of markers linked to</span></p>
<p style="top:619.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neurodegeneration, such as brain iron accumulation,</span></p>
<p style="top:632.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neurotransmitter levels, and oxidative stress markers;</span></p>
<p style="top:644.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and brain morphometry. Therefore, animal studies with</span></p>
<p style="top:657.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">diverse outcome measures were included. Human stud-</span></p>
<p style="top:669.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ies included were those that estimated former or cur-</span></p>
<p style="top:682.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">rent levels of iron intake or peripheral measures of iron</span></p>
<p style="top:694.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">status and their effect on brain iron, cognition, and/or</span></p>
<p style="top:707.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the onset of neurodegenerative disease in adults. Details</span></p>
<p style="top:737.1pt;left:60.0pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:116.1pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:737.1pt;left:524.9pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">457</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:331.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of the inclusion and exclusion criteria are provided in</span></p>
<p style="top:343.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 1</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">.</span></p>
<p style="top:370.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Assessment of risk of publication bias in</span></p>
<p style="top:382.3pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">preclinical studies</span></p>
<p style="top:406.5pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Comparing the number of studies reporting negative</span></p>
<p style="top:419.0pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">findings in the unpublished versus the published literature</span></p>
<p style="top:431.5pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">is one way to assess publication bias. Risk of publication</span></p>
<p style="top:444.0pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">bias was assessed by one author (S.A.). The Society for</span></p>
<p style="top:456.5pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Neuroscience&#x2019;s online database is a collection of abstracts</span></p>
<p style="top:469.0pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">presented at annual meetings; the years 2007&#x2013;2015 were</span></p>
<p style="top:481.5pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">searched. Relevant abstracts were evaluated for the pres-</span></p>
<p style="top:494.0pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ence of positive or negative findings but were not included</span></p>
<p style="top:506.5pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">as part of the review. Permission was obtained from the</span></p>
<p style="top:519.0pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Society for Neuroscience to access this private database.</span></p>
<p style="top:545.8pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Risk of bias</span></p>
<p style="top:569.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The quality of the included papers was assessed at the</span></p>
<p style="top:582.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">study level. For animal studies, 7 indicators of quality</span></p>
<p style="top:594.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">adapted from the National Research Council&#x2019;s Institute</span></p>
<p style="top:607.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">for Laboratory Animal Research were used</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">30</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">31</span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">: (1) ran-</span></p>
<p style="top:619.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">dom allocation of treatment, (2) allocation concealment,</span></p>
<p style="top:632.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">(3) blinding, (4) stated inclusion/exclusion criteria, (5) test</span></p>
<p style="top:644.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">animal details, (6) every animal accounted for, and (7)</span></p>
<p style="top:657.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">conflict of interest statement and funding source. Human</span></p>
<p style="top:669.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">cohort and case&#x2013;control studies were analyzed using tools</span></p>
<p style="top:682.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">from the Critical Appraisal Skills Program, while cross-</span></p>
<p style="top:694.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">sectional studies were assessed using tools modified from</span></p>
<p style="top:707.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">those recommended by the Agency for Healthcare</span></p>
<p style="top:331.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Research and Quality.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">32</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The criteria were assessed inde-</span></p>
<p style="top:343.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">pendently by two reviewers (S.A. and J.H.F.); discrepan-</span></p>
<p style="top:356.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">cies were resolved by discussion.</span></p>
<p style="top:382.4pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Data extraction and synthesis</span></p>
<p style="top:406.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Study characteristics and data were extracted and evalu-</span></p>
<p style="top:419.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ated by two authors independently (S.A. and J.H.F.),</span></p>
<p style="top:431.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">with</span></p>
<p style="top:431.5pt;left:333.5pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">discrepancies</span></p>
<p style="top:431.5pt;left:396.2pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">resolved</span></p>
<p style="top:431.5pt;left:438.4pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">by</span></p>
<p style="top:431.5pt;left:456.8pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">discussion.</span></p>
<p style="top:431.5pt;left:509.7pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Meta-</span></p>
<p style="top:444.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">analysis was not possible because of the heterogeneous</span></p>
<p style="top:456.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">nature of the studies and the varied outcomes. Papers</span></p>
<p style="top:469.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">were grouped into 4 themes: preclinical studies of the</span></p>
<p style="top:481.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">effect of high iron intake on outcomes related to behav-</span></p>
<p style="top:494.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ior and brain aging (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 2</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">)</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">33</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">51</span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">; preclinical studies of</span></p>
<p style="top:506.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the effect of high iron intake on outcomes related to</span></p>
<p style="top:519.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neurodegenerative disease (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 3</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">)</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">52</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">66</span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">; human nutrition</span></p>
<p style="top:531.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">studies assessing the association between iron intake</span></p>
<p style="top:544.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and brain outcomes (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 4</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">)</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">67</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">72</span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">; and human stud-</span></p>
<p style="top:556.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ies assessing the association between peripheral iron</span></p>
<p style="top:569.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">status and brain outcomes (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 5</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">).</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">73</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">80</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Qualitative</span></p>
<p style="top:581.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">synthesis of the included studies was completed</span></p>
<p style="top:594.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">within and across the 4 themes. All findings reported</span></p>
<p style="top:606.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">in</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> Tables 2</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">,</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> 3</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">,</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> 4</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">, and</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> 5</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> are statistically significant un-</span></p>
<p style="top:619.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">less otherwise stated.</span></p>
<p style="top:645.8pt;left:402.3pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">RESULTS</span></p>
<p style="top:670.8pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Description of the included studies</span></p>
<p style="top:694.9pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">A PRISMA flow chart showing papers included and ex-</span></p>
<p style="top:707.4pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">cluded at each step is shown in (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Figure 1</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">). A total of</span></p>
<p style="top:44.6pt;left:62.0pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 1</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> PICOS criteria for inclusion and exclusion of studies</span></p>
<p style="top:58.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Category</span></p>
<p style="top:58.2pt;left:196.1pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Inclusion criteria</span></p>
<p style="top:58.2pt;left:409.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Exclusion criteria</span></p>
<p style="top:73.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Participants</span></p>
<p style="top:73.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Animal studies: mammals</span></p>
<p style="top:83.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Human studies: all races and both sexes</span></p>
<p style="top:73.5pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Animal studies: nonmammalian species</span></p>
<p style="top:83.5pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Human studies: hemochromatosis or neurologic</span></p>
<p style="top:93.4pt;left:347.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">disease diagnosis before determination of iron</span></p>
<p style="top:103.5pt;left:347.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">status or intake level</span></p>
<p style="top:113.4pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Intervention</span></p>
<p style="top:113.4pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Animal studies: oral administration of iron supplements</span></p>
<p style="top:123.5pt;left:134.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">or high-iron diets</span></p>
<p style="top:133.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Human studies: iron supplementation or estimation of</span></p>
<p style="top:143.4pt;left:134.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron intake or peripheral iron status at any age</span></p>
<p style="top:113.4pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Parenteral administration of iron</span></p>
<p style="top:123.5pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Toxic level of iron supplementation in animals</span></p>
<p style="top:133.5pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Studies of effects of maternal iron intake on progeny</span></p>
<p style="top:143.4pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Studies of iron supplementation in the context of</span></p>
<p style="top:153.5pt;left:347.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">deficiency</span></p>
<p style="top:163.4pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Comparator</span></p>
<p style="top:163.4pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Control group for iron intake in animal and human</span></p>
<p style="top:173.4pt;left:134.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">experimental studies</span></p>
<p style="top:183.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Human studies: sex and age matched, absence of</span></p>
<p style="top:193.4pt;left:134.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">neurologic disease, lower natural iron intake or lower</span></p>
<p style="top:203.5pt;left:134.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">peripheral iron status</span></p>
<p style="top:163.5pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">None</span></p>
<p style="top:213.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcomes</span></p>
<p style="top:213.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Animal studies: behavior, brain biochemistry, and</span></p>
<p style="top:223.4pt;left:134.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">neuropathology</span></p>
<p style="top:233.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Human studies: development of neurodegenerative</span></p>
<p style="top:243.4pt;left:134.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">disease, markers of brain iron status, cognition</span></p>
<p style="top:213.5pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Animal and human studies: outcomes measured in</span></p>
<p style="top:223.4pt;left:349.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">preadults</span></p>
<p style="top:253.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Study design</span></p>
<p style="top:253.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Experimental animal studies</span></p>
<p style="top:263.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Human studies: randomized controlled nutritional</span></p>
<p style="top:273.4pt;left:134.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">studies, all types of observational studies</span></p>
<p style="top:283.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">English language</span></p>
<p style="top:293.5pt;left:128.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Dated up to June 2016</span></p>
<p style="top:253.5pt;left:341.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Meta-analyses, reviews, gray literature, short commu-</span></p>
<p style="top:263.5pt;left:349.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">nications, abstracts, and case reports</span></p>
<p style="top:737.1pt;left:56.0pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">458</span></p>
<p style="top:737.1pt;left:413.2pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:469.4pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:701.5pt;left:57.6pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 2</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> Preclinical studies evaluating the effect of high iron intake on outcomes related to behavior and brain aging</span></p>
<p style="top:701.9pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Reference</span></p>
<p style="top:586.8pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Sex/strain/species</span></p>
<p style="top:495.4pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron form and dosage</span></p>
<p style="top:469.6pt;left:80.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">range</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span></p>
<p style="top:397.9pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Age at iron supplementation</span></p>
<p style="top:400.5pt;left:82.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and at outcome measurement</span></p>
<p style="top:273.5pt;left:70.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Bias assessment</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span></p>
<p style="top:181.7pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Major effects of iron supplementation</span></p>
<p style="top:701.9pt;left:96.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fredriksson et al. (1999)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">41</span></p>
<p style="top:598.1pt;left:97.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male NMRI mice</span></p>
<p style="top:500.1pt;left:97.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:107.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">3.7&#x2013;37 mg/kg</span></p>
<p style="top:402.3pt;left:97.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:402.3pt;left:107.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.4pt;left:97.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, H</span></p>
<p style="top:194.6pt;left:97.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation produced deficits in</span></p>
<p style="top:186.5pt;left:107.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">spontaneous activity and spatial learn-</span></p>
<p style="top:186.5pt;left:117.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">ing. Iron levels in basal ganglia were in-</span></p>
<p style="top:186.5pt;left:127.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">creased 22%&#x2013;58%. No effect on frontal</span></p>
<p style="top:186.5pt;left:137.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cortical iron</span></p>
<p style="top:701.9pt;left:146.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fredriksson et al. (2000)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">42</span></p>
<p style="top:598.1pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male NMRI mice</span></p>
<p style="top:500.1pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:157.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">7.5 mg/kg</span></p>
<p style="top:402.3pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 3&#x2013;5 d, 10&#x2013;12 d, and</span></p>
<p style="top:396.3pt;left:157.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">19&#x2013;21 d</span></p>
<p style="top:402.3pt;left:167.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.4pt;left:146.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation on days 3&#x2013;5 and 10&#x2013;12</span></p>
<p style="top:186.5pt;left:157.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">resulted in (1) deficits in spontaneous ac-</span></p>
<p style="top:186.5pt;left:167.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tivity and spatial learning and (2) a</span></p>
<p style="top:186.5pt;left:177.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">26%&#x2013;48% increase in basal ganglia iron</span></p>
<p style="top:701.9pt;left:186.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Isacc et al. (2006)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">43</span></p>
<p style="top:598.1pt;left:187.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male C57 BL/6 mice</span></p>
<p style="top:500.1pt;left:187.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:197.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">7.5 mg/kg</span></p>
<p style="top:402.3pt;left:187.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:402.3pt;left:197.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3&#x2013;4 mo</span></p>
<p style="top:280.4pt;left:186.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:187.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron-supplemented mice had decreases in</span></p>
<p style="top:186.5pt;left:197.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">brain phosphatidyl choline and sphingo-</span></p>
<p style="top:186.5pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">myelin levels</span></p>
<p style="top:701.9pt;left:216.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">de Lima et al. (2005)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">49</span></p>
<p style="top:598.1pt;left:217.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:500.1pt;left:217.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:402.3pt;left:217.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 5&#x2013;7 d, 12&#x2013;14 d, 19&#x2013;21 d,</span></p>
<p style="top:396.3pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and 30&#x2013;32 d</span></p>
<p style="top:402.3pt;left:237.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.4pt;left:216.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:217.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation of iron on days 12&#x2013;14 (1)</span></p>
<p style="top:186.5pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">impaired object recognition by</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">36%</span></p>
<p style="top:186.5pt;left:237.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and (2) increased oxidative stress in hip-</span></p>
<p style="top:186.5pt;left:247.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">pocampus and substantia nigra</span></p>
<p style="top:701.9pt;left:256.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Miwa et al. (2011)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">51</span></p>
<p style="top:598.1pt;left:257.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:500.1pt;left:257.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:267.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:402.3pt;left:257.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:402.3pt;left:267.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3&#x2013;24 mo</span></p>
<p style="top:280.4pt;left:256.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:257.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation increased expression of</span></p>
<p style="top:186.5pt;left:267.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">the apoptosis markers prostate apoptosis</span></p>
<p style="top:186.5pt;left:277.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">response-4 and caspase-3 protein at</span></p>
<p style="top:186.5pt;left:287.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">3 mo but decreased expression at 24 mo</span></p>
<p style="top:701.9pt;left:296.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fernandez et al. (2011)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">39</span></p>
<p style="top:598.1pt;left:297.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:500.1pt;left:297.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:307.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:402.3pt;left:297.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:402.3pt;left:307.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3&#x2013;24 mo</span></p>
<p style="top:280.4pt;left:296.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:297.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation induced mild astro-</span></p>
<p style="top:186.5pt;left:307.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cytosis in hippocampus at 3 mo and in</span></p>
<p style="top:186.5pt;left:317.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">striatum and substantia nigra at 24 mo</span></p>
<p style="top:701.9pt;left:326.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Schroder et al. (2001)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">46</span></p>
<p style="top:598.1pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:500.1pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:337.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">2.5&#x2013;30.0 mg/kg</span></p>
<p style="top:402.3pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:402.3pt;left:337.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3&#x2013;6 mo</span></p>
<p style="top:280.4pt;left:326.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation resulted in (1) dose-de-</span></p>
<p style="top:186.5pt;left:337.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">pendent deficits in radial arm maze</span></p>
<p style="top:186.5pt;left:347.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">learning and (2) a 46%&#x2013;92% increase in</span></p>
<p style="top:186.5pt;left:357.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">substantia nigra iron content</span></p>
<p style="top:701.9pt;left:366.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Figueiredo et al. (2016)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">40</span></p>
<p style="top:598.1pt;left:367.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:500.1pt;left:367.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Carbonyl iron; 10 mg/kg</span></p>
<p style="top:402.3pt;left:367.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:402.3pt;left:377.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.4pt;left:366.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L, U, L</span></p>
<p style="top:194.6pt;left:367.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation (1) impaired emo-</span></p>
<p style="top:186.5pt;left:377.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tionally motivated behavior and recogni-</span></p>
<p style="top:186.5pt;left:387.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tion memory and (2) increased</span></p>
<p style="top:186.5pt;left:397.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">hippocampal protein ubiquitination</span></p>
<p style="top:701.9pt;left:406.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Dornelles et al. (2010)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">38</span></p>
<p style="top:598.1pt;left:407.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:500.1pt;left:407.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:417.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:402.3pt;left:407.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:402.3pt;left:417.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3&#x2013;24 mo</span></p>
<p style="top:280.4pt;left:406.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:407.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation changed expression of</span></p>
<p style="top:186.5pt;left:417.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mRNA encoding genes involved in iron</span></p>
<p style="top:186.5pt;left:427.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">homeostasis in an age- and brain-re-</span></p>
<p style="top:186.5pt;left:437.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">gion-specific manner</span></p>
<p style="top:701.9pt;left:446.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">de Lima et al. (2005)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">35</span></p>
<p style="top:598.1pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:500.1pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:457.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:402.3pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:402.3pt;left:457.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.4pt;left:446.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Monoamine oxidase inhibition protected</span></p>
<p style="top:186.5pt;left:457.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">against behavioral effects of iron</span></p>
<p style="top:186.5pt;left:467.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">supplementation</span></p>
<p style="top:701.9pt;left:476.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Budni et al. (2007)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">34</span></p>
<p style="top:598.1pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:500.1pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:492.2pt;left:487.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:402.3pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:402.3pt;left:487.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.4pt;left:476.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.6pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Monoamine oxidase inhibition decreased</span></p>
<p style="top:186.5pt;left:487.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron supplementation&#x2013;induced oxidative</span></p>
<p style="top:186.5pt;left:497.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">stress in substantia nigra and</span></p>
<p style="top:186.5pt;left:507.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">hippocampus</span></p>
<p style="top:78.2pt;left:522.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(continued)</span></p>
<p style="top:737.1pt;left:60.0pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:116.1pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:737.1pt;left:524.9pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">459</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:701.0pt;left:52.9pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 2</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> Continued</span></p>
<p style="top:701.4pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Reference</span></p>
<p style="top:586.3pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Sex/strain/species</span></p>
<p style="top:494.9pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron form and dosage</span></p>
<p style="top:469.0pt;left:75.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">range</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span></p>
<p style="top:397.4pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Age at iron supplementation</span></p>
<p style="top:400.0pt;left:76.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and at outcome measurement</span></p>
<p style="top:273.0pt;left:65.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Bias assessment</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span></p>
<p style="top:181.2pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Major effects of iron supplementation</span></p>
<p style="top:701.4pt;left:90.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">de Lima et al. (2008)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">37</span></p>
<p style="top:597.5pt;left:92.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:499.6pt;left:92.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:491.6pt;left:102.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:401.8pt;left:92.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:401.8pt;left:102.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:279.9pt;left:90.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.0pt;left:92.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Type 4&#x2013;specific phosphodiesterase inhibi-</span></p>
<p style="top:186.0pt;left:102.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tion protected against cognitive effects</span></p>
<p style="top:186.0pt;left:112.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">of iron supplementation</span></p>
<p style="top:701.4pt;left:120.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">de Lima et al. (2007)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">36</span></p>
<p style="top:597.5pt;left:122.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:499.6pt;left:122.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:491.6pt;left:132.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:401.8pt;left:122.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:401.8pt;left:132.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:279.9pt;left:120.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.0pt;left:122.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron chelation with desferoxamine pro-</span></p>
<p style="top:186.0pt;left:132.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tected against behavioral effects of iron</span></p>
<p style="top:186.0pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">supplementation</span></p>
<p style="top:701.4pt;left:150.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Rech et al. (2010)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">45</span></p>
<p style="top:597.5pt;left:152.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:499.6pt;left:152.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:491.6pt;left:162.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:401.8pt;left:152.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:401.8pt;left:162.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 24 mo</span></p>
<p style="top:279.9pt;left:150.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.0pt;left:152.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No significant effect of neonatal iron sup-</span></p>
<p style="top:186.0pt;left:162.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">plementation on motor activity or novel</span></p>
<p style="top:186.0pt;left:172.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">object recognition</span></p>
<p style="top:701.4pt;left:180.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fagherazzi et al. (2012)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">50</span></p>
<p style="top:597.5pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:499.7pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous carbonyl;</span></p>
<p style="top:491.6pt;left:192.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:401.8pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:401.8pt;left:192.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 2.5 mo</span></p>
<p style="top:279.9pt;left:180.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.0pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cannabidiol protected against deleterious</span></p>
<p style="top:186.0pt;left:192.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">effects of neonatal iron supplementation</span></p>
<p style="top:701.4pt;left:200.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">da Silva et al. (2014)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">47</span></p>
<p style="top:597.5pt;left:202.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:499.6pt;left:202.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 10 mg/kg</span></p>
<p style="top:401.8pt;left:202.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:401.8pt;left:212.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3.5 mo</span></p>
<p style="top:279.9pt;left:202.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span></p>
<p style="top:194.0pt;left:202.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cannabidiol normalized cortical caspase-3,</span></p>
<p style="top:186.0pt;left:212.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">synaptophysin, and mitochondrial fission</span></p>
<p style="top:186.0pt;left:222.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">dynamin-1-like protein</span></p>
<p style="top:701.4pt;left:230.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Perez et al. (2010)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">44</span></p>
<p style="top:597.5pt;left:232.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:499.6pt;left:232.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:491.6pt;left:242.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">10 mg/kg</span></p>
<p style="top:401.8pt;left:232.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:401.8pt;left:242.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 2&#x2013;3 mo</span></p>
<p style="top:279.9pt;left:230.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.0pt;left:232.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation impaired long-term ob-</span></p>
<p style="top:186.0pt;left:242.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">ject recognition (</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">28%) and decreased</span></p>
<p style="top:186.0pt;left:252.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">striatal acetylcholinesterase activity</span></p>
<p style="top:186.0pt;left:262.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">27%)</span></p>
<p style="top:701.4pt;left:270.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Silva et al. (2012)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">48</span></p>
<p style="top:597.5pt;left:272.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:499.6pt;left:272.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 10 mg/kg</span></p>
<p style="top:401.8pt;left:272.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:401.8pt;left:282.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 2 mo</span></p>
<p style="top:279.9pt;left:270.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:194.0pt;left:272.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation decreased object recog-</span></p>
<p style="top:186.0pt;left:282.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">nition memory (</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">29%). Iron-induced</span></p>
<p style="top:186.0pt;left:292.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">changes in histone acetylation in hippo-</span></p>
<p style="top:186.0pt;left:302.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">campus were rescued with butyrate</span></p>
<p style="top:701.4pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Lavich et al. (2015)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">33</span></p>
<p style="top:597.5pt;left:312.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats</span></p>
<p style="top:499.6pt;left:312.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 10 mg/kg</span></p>
<p style="top:401.8pt;left:312.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:401.8pt;left:322.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:279.9pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L, U, L</span></p>
<p style="top:194.0pt;left:312.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Supplementation decreased novel object</span></p>
<p style="top:186.0pt;left:322.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">recognition (</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">32%) and impaired mito-</span></p>
<p style="top:186.0pt;left:332.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">chondrial dynamics. Effects of iron were</span></p>
<p style="top:186.0pt;left:342.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">rescued with the antioxidant</span></p>
<p style="top:186.0pt;left:352.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">sulforaphane</span></p>
<p style="top:701.4pt;left:362.9pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">Abbreviations</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">: H, high risk of bias; L, low risk of bias; U, unclear risk of bias.</span></p>
<p style="top:703.5pt;left:371.5pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron was delivered by gavage.</span></p>
<p style="top:703.5pt;left:381.5pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Left to right: random allocation of treatment, concealment of allocation, blinding, inclusion/exclusion criteria, test animal details, every animal accounted for, and conflicts of interest and</span></p>
<p style="top:701.4pt;left:390.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">funding sources reported.</span></p>
<p style="top:703.5pt;left:399.5pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Only funding information was reported.</span></p>
<p style="top:703.5pt;left:409.5pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Only behavioral studies were blinded.</span></p>
<p style="top:737.1pt;left:56.0pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">460</span></p>
<p style="top:737.1pt;left:413.2pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:469.4pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:700.7pt;left:57.6pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 3</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> Preclinical studies evaluating the effect of high iron intake on outcomes related to neurodegenerative disease</span></p>
<p style="top:701.1pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Reference</span></p>
<p style="top:580.5pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Sex/strain/species/</span></p>
<p style="top:577.3pt;left:82.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">disease modeled</span></p>
<p style="top:485.0pt;left:70.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron form and dosage</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span></p>
<p style="top:383.8pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Age(s) at supplementation</span></p>
<p style="top:365.4pt;left:82.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and at outcome</span></p>
<p style="top:361.8pt;left:92.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">measurement</span></p>
<p style="top:277.0pt;left:70.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Bias assessment</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span></p>
<p style="top:186.9pt;left:72.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Major effects of iron supplementation</span></p>
<p style="top:701.1pt;left:106.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fredriksson et al. (2001)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">62</span></p>
<p style="top:590.3pt;left:107.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male C57BL/6 mice; PD</span></p>
<p style="top:497.2pt;left:107.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate; 7.5 mg/kg</span></p>
<p style="top:386.0pt;left:107.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:386.0pt;left:117.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3&#x2013;4 mo</span></p>
<p style="top:280.9pt;left:106.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:205.7pt;left:107.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation increased basal ganglia</span></p>
<p style="top:197.7pt;left:117.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron by 72%. Supplementation and adult</span></p>
<p style="top:197.7pt;left:127.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">neurotoxic MPTP treatment potentiated the</span></p>
<p style="top:197.7pt;left:137.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">depletion of basal ganglia dopamine</span></p>
<p style="top:701.1pt;left:146.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fredriksson et al. (2003)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">60</span></p>
<p style="top:590.3pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male C57BL/6 mice; PD</span></p>
<p style="top:497.2pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:489.2pt;left:157.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">2.5&#x2013;7.5 mg/kg</span></p>
<p style="top:386.0pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:386.0pt;left:157.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3&#x2013;4 mo</span></p>
<p style="top:280.9pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, H</span></p>
<p style="top:205.7pt;left:147.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation increased basal ganglia</span></p>
<p style="top:197.7pt;left:157.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron up to 102%. N-methyl-D-aspartate an-</span></p>
<p style="top:197.7pt;left:167.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tagonist MK801 with L-DOPA partly rescued</span></p>
<p style="top:197.7pt;left:177.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">motor effects of iron supplementation</span></p>
<p style="top:701.1pt;left:186.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fredriksson &amp; Archer (2003)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">52</span></p>
<p style="top:590.3pt;left:187.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male NMRI and C57BL/6</span></p>
<p style="top:582.3pt;left:197.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mice; PD</span></p>
<p style="top:497.2pt;left:187.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:489.2pt;left:197.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">2.5&#x2013;37 mg/kg</span></p>
<p style="top:386.0pt;left:187.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:386.0pt;left:197.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3&#x2013;4 mo</span></p>
<p style="top:280.9pt;left:186.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, U, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:205.7pt;left:187.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation increased basal ganglia</span></p>
<p style="top:197.7pt;left:197.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron by 58% and decreased motor activities.</span></p>
<p style="top:197.7pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">MPTP potentiated effects of neonatal iron</span></p>
<p style="top:197.7pt;left:217.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">supplementation</span></p>
<p style="top:701.1pt;left:226.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Kaur et al. (2007)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">63</span></p>
<p style="top:590.3pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male C57BL/6</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> D2</span></p>
<p style="top:582.3pt;left:237.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mice; PD</span></p>
<p style="top:497.2pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 120 mg/kg</span></p>
<p style="top:386.0pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;17 d</span></p>
<p style="top:386.0pt;left:237.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 2&#x2013;24 mo</span></p>
<p style="top:280.9pt;left:226.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:205.7pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation decreased striatal dopa-</span></p>
<p style="top:197.7pt;left:237.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mine by up to</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">44%, decreased dopami-</span></p>
<p style="top:197.7pt;left:247.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">nergic neurons in the substantia nigra by up</span></p>
<p style="top:197.7pt;left:257.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">to</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">29%, and enhanced the neurotoxic</span></p>
<p style="top:197.7pt;left:267.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">effects of MPTP</span></p>
<p style="top:701.1pt;left:276.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Peng et al. (2007)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">65</span></p>
<p style="top:590.3pt;left:277.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male C57BL/6 mice; PD</span></p>
<p style="top:497.2pt;left:277.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 120 mg/kg</span></p>
<p style="top:386.0pt;left:277.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;17 d</span></p>
<p style="top:386.0pt;left:287.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 2&#x2013;24 mo</span></p>
<p style="top:280.9pt;left:277.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, H</span></p>
<p style="top:205.7pt;left:277.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation decreased dopaminergic</span></p>
<p style="top:197.7pt;left:287.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cells at 24 mo by</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">25%; the herbicide para-</span></p>
<p style="top:197.7pt;left:297.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">quat potentiated this effect; a superoxide</span></p>
<p style="top:197.7pt;left:307.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">dismutase/catalase mimetic provided some</span></p>
<p style="top:197.7pt;left:317.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">protection</span></p>
<p style="top:701.1pt;left:326.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Archer &amp; Fredriksson (2007)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">54</span></p>
<p style="top:590.3pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male C57/BL6 mice; PD</span></p>
<p style="top:497.2pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate; 7.5 mg/kg</span></p>
<p style="top:386.0pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:386.0pt;left:337.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.9pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, H</span></p>
<p style="top:205.7pt;left:327.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation increased basal ganglia</span></p>
<p style="top:197.7pt;left:337.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron by</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">67%. Neuroleptic agents modu-</span></p>
<p style="top:197.7pt;left:347.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">lated behavioral effects of iron</span></p>
<p style="top:701.1pt;left:356.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fredriksson &amp; Archer (2006)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">61</span></p>
<p style="top:590.3pt;left:357.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male C57/BL6 mice; PD</span></p>
<p style="top:497.2pt;left:357.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate; 7.5 mg/kg</span></p>
<p style="top:386.0pt;left:357.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:386.0pt;left:367.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.9pt;left:357.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, H</span></p>
<p style="top:205.7pt;left:357.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Neuroleptic agent haloperidol modulated the</span></p>
<p style="top:197.7pt;left:367.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">behavioral effects of iron supplementation</span></p>
<p style="top:701.1pt;left:376.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Wang et al. (2014)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">53</span></p>
<p style="top:590.3pt;left:377.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Sprague-Dawley</span></p>
<p style="top:582.3pt;left:387.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">rats; PD</span></p>
<p style="top:497.2pt;left:377.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 120 mg/kg</span></p>
<p style="top:386.0pt;left:377.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;17 d</span></p>
<p style="top:386.0pt;left:387.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 20 mo</span></p>
<p style="top:280.9pt;left:376.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:205.7pt;left:377.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation reduced motor activity</span></p>
<p style="top:197.7pt;left:387.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and decreased striatal dopamine by</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">38%.</span></p>
<p style="top:197.7pt;left:397.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Inhibition of sirtuin 2 provided some</span></p>
<p style="top:197.7pt;left:407.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">protection</span></p>
<p style="top:701.1pt;left:416.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Peng et al. (2010)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">64</span></p>
<p style="top:590.3pt;left:417.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male mutant</span><span style="font-family:AdvPSMP10,serif;font-size:9.0pt"> a</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">-synu-</span></p>
<p style="top:582.3pt;left:427.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">clein mice (C57BL/</span></p>
<p style="top:582.3pt;left:437.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">6 strain); PD</span></p>
<p style="top:497.2pt;left:417.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 120 mg/kg</span></p>
<p style="top:386.0pt;left:417.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;17 d</span></p>
<p style="top:386.0pt;left:427.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 12&#x2013;23 mo</span></p>
<p style="top:280.9pt;left:417.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, H</span></p>
<p style="top:205.7pt;left:417.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Interaction between mutant</span><span style="font-family:AdvPSMP10,serif;font-size:9.0pt"> a</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">-synuclein and</span></p>
<p style="top:197.7pt;left:427.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfe;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> paraquat combination treatment</span></p>
<p style="top:197.7pt;left:437.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">promoted loss of dopaminergic neurons</span></p>
<p style="top:701.1pt;left:446.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Dal-Pizzol et al. (2001)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">58</span></p>
<p style="top:590.3pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male Wistar rats; PD</span></p>
<p style="top:497.2pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate;</span></p>
<p style="top:489.2pt;left:457.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">7.5&#x2013;15 mg/kg</span></p>
<p style="top:386.0pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;12 d</span></p>
<p style="top:386.0pt;left:457.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:280.9pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, H</span></p>
<p style="top:205.7pt;left:447.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Neonatal iron supplementation increased</span></p>
<p style="top:197.7pt;left:457.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">substantia nigra lipid peroxidation by</span></p>
<p style="top:197.7pt;left:467.6pt;line-height:9.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">48%&#x2013;66%</span></p>
<p style="top:701.1pt;left:476.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Chen et al. (2015)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">57</span></p>
<p style="top:590.3pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male/female Sprague-</span></p>
<p style="top:582.3pt;left:487.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Dawley rats; PD</span></p>
<p style="top:497.2pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 120 mg/kg</span></p>
<p style="top:386.0pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;17 d</span></p>
<p style="top:386.0pt;left:487.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 7&#x2013;21 mo</span></p>
<p style="top:280.9pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span></p>
<p style="top:205.7pt;left:477.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation decreased motor activ-</span></p>
<p style="top:197.7pt;left:487.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">ity, striatal dopamine (</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">35%), and substan-</span></p>
<p style="top:197.7pt;left:497.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tia nigra glutathione (</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">40%) and increased</span></p>
<p style="top:197.7pt;left:507.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">nigral lipid peroxidation (</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">100%)</span></p>
<p style="top:77.4pt;left:522.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(continued)</span></p>
<p style="top:737.1pt;left:60.0pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:116.1pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:737.1pt;left:524.9pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">461</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:701.7pt;left:52.9pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 3</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> Continued</span></p>
<p style="top:702.1pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Reference</span></p>
<p style="top:581.6pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Sex/strain/species/</span></p>
<p style="top:578.4pt;left:76.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">disease modeled</span></p>
<p style="top:486.0pt;left:65.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron form and dosage</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span></p>
<p style="top:384.8pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Age(s) at supplementation</span></p>
<p style="top:366.4pt;left:76.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and at outcome</span></p>
<p style="top:362.9pt;left:86.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">measurement</span></p>
<p style="top:278.1pt;left:65.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Bias assessment</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span></p>
<p style="top:187.9pt;left:66.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Major effects of iron supplementation</span></p>
<p style="top:702.1pt;left:100.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Billings et al. (2016)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">56</span></p>
<p style="top:591.4pt;left:102.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male</span><span style="font-family:AdvPSMP10,serif;font-size:9.0pt"> a</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">-synuclein trans-</span></p>
<p style="top:583.4pt;left:112.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">genic mice (C57BL/6</span></p>
<p style="top:583.4pt;left:122.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">strain); PD</span></p>
<p style="top:498.2pt;left:102.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 120 mg/kg</span></p>
<p style="top:387.1pt;left:102.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;17 d</span></p>
<p style="top:387.1pt;left:112.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 8 mo</span></p>
<p style="top:281.9pt;left:100.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:206.8pt;left:102.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation promoted loss of dopa-</span></p>
<p style="top:198.8pt;left:112.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">minergic neurons in wild-type mice by</span></p>
<p style="top:198.8pt;left:122.2pt;line-height:9.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt">&#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">30% but not in mutant</span><span style="font-family:AdvPSMP10,serif;font-size:9.0pt"> a</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">-synuclein trans-</span></p>
<p style="top:198.8pt;left:132.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">genic mice</span></p>
<p style="top:702.1pt;left:140.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Fernandez et al. (2010)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">59</span></p>
<p style="top:591.4pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Male A</span><span style="font-family:AdvPSMP10,serif;font-size:9.0pt">b</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">PP/PS1 trans-</span></p>
<p style="top:583.4pt;left:152.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">genic mice; AD</span></p>
<p style="top:498.2pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ferrous succinate; 10 mg/kg</span></p>
<p style="top:387.1pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 12&#x2013;14 d</span></p>
<p style="top:387.1pt;left:152.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 6 mo</span></p>
<p style="top:281.9pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U, U, U, U, U, U, L</span></p>
<p style="top:206.8pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron supplementation increased astrocytosis in</span></p>
<p style="top:198.8pt;left:152.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">the cerebral cortex of transgenic and wild-</span></p>
<p style="top:198.8pt;left:162.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">type mice. No effect of iron on amyloid</span></p>
<p style="top:198.8pt;left:172.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">plaques</span></p>
<p style="top:702.1pt;left:180.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Berggren et al. (2015)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">55</span></p>
<p style="top:591.4pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Female R6/2 mice (B6/</span></p>
<p style="top:583.4pt;left:192.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">CBA stain); HD</span></p>
<p style="top:498.2pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 120 mg/kg for</span></p>
<p style="top:490.2pt;left:192.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">neonates, 500 mg/kg for</span></p>
<p style="top:490.2pt;left:202.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">adults</span></p>
<p style="top:387.1pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;17 d and 1&#x2013;3 mo</span></p>
<p style="top:381.1pt;left:192.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(in feed)</span></p>
<p style="top:387.1pt;left:202.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 3 mo</span></p>
<p style="top:281.9pt;left:180.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">e</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L, U, L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:206.8pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Neonatal iron supplementation increased the</span></p>
<p style="top:198.8pt;left:192.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">oxidative stress marker oxidized glutathione</span></p>
<p style="top:198.8pt;left:202.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(32%&#x2013;53%) and neuronal atrophy</span></p>
<p style="top:198.8pt;left:212.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(13%&#x2013;15%) in HD but not in wild-type</span></p>
<p style="top:198.8pt;left:222.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">brains. There was no effect of iron</span></p>
<p style="top:198.8pt;left:232.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">supplementation during adult life</span></p>
<p style="top:702.1pt;left:240.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Berggren et al. (2016)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">66</span></p>
<p style="top:591.4pt;left:242.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Female YAC128 HD</span></p>
<p style="top:583.4pt;left:252.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mice (FVB strain); HD</span></p>
<p style="top:498.2pt;left:242.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron carbonyl; 120 mg/kg for</span></p>
<p style="top:490.2pt;left:252.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">neonates, 500 mg/kg for</span></p>
<p style="top:490.2pt;left:262.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">adults</span></p>
<p style="top:387.1pt;left:242.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron: 10&#x2013;17 d and 1&#x2013;12 mo</span></p>
<p style="top:381.1pt;left:252.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(in feed)</span></p>
<p style="top:387.1pt;left:262.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome: 12 mo</span></p>
<p style="top:281.9pt;left:240.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">L</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, U</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">e</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">, U, L, U, L</span></p>
<p style="top:206.8pt;left:242.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Neonatal iron supplementation promoted</span></p>
<p style="top:198.8pt;left:252.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">striatal neuronal atrophy in HD mice (19%)</span></p>
<p style="top:198.8pt;left:262.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">but not in wild-type littermates. There was</span></p>
<p style="top:198.8pt;left:272.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">no effect of iron supplementation during</span></p>
<p style="top:198.8pt;left:282.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">adult life</span></p>
<p style="top:702.1pt;left:292.9pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">Abbreviations</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">: AD, Alzheimer disease; H, high risk of bias; HD, Huntington disease; L, low risk of bias; L-DOPA, L-3,4-dihydroxyphenylalanine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri-</span></p>
<p style="top:702.1pt;left:301.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">dine; PD, Parkinson disease; U, unclear risk of bias.</span></p>
<p style="top:704.2pt;left:310.1pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron was delivered by gavage to neonates and in feed to adults.</span></p>
<p style="top:704.2pt;left:320.1pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Left to right: random allocation of treatment, concealment of allocation, blinding, inclusion/exclusion criteria, test animal details, every animal accounted for, and conflicts of interest and</span></p>
<p style="top:702.1pt;left:330.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">funding sources reported.</span></p>
<p style="top:704.2pt;left:338.8pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Only funding information was reported.</span></p>
<p style="top:704.2pt;left:348.7pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Whole litters were randomized to receive iron supplementation.</span></p>
<p style="top:704.2pt;left:358.8pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">e</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Only histopathology studies were blinded.</span></p>
<p style="top:737.1pt;left:56.0pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">462</span></p>
<p style="top:737.1pt;left:413.2pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:469.4pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:472.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">2531 potentially relevant articles were identified. After</span></p>
<p style="top:485.5pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">screening titles and abstracts, 129 papers were identified</span></p>
<p style="top:497.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">for full-text evaluation. After reviewing, 81 papers were</span></p>
<p style="top:510.5pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">excluded. Of the 48 included papers, 34 described pre-</span></p>
<p style="top:522.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">clinical studies. Nineteen of these focused primarily on</span></p>
<p style="top:535.5pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">behavioral and age-related outcomes (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 2</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">), and 15</span></p>
<p style="top:547.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">focused on outcomes related to neurodegenerative pro-</span></p>
<p style="top:560.5pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">cesses (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 3</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">). Fourteen studies were conducted in</span></p>
<p style="top:572.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">humans: 6 assessed associations between iron nutrition</span></p>
<p style="top:585.5pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and brain outcomes (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 4</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">), and 8 assessed associa-</span></p>
<p style="top:597.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tions between peripheral iron status and brain out-</span></p>
<p style="top:610.5pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">comes (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 5</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">).</span></p>
<p style="top:645.8pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Assessment of risk of publication bias</span></p>
<p style="top:669.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">After searching meeting abstracts from 9 years of the</span></p>
<p style="top:682.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Society for Neuroscience&#x2019;s database, 5 studies were</span></p>
<p style="top:694.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">found that addressed the role of elevated nutritional</span></p>
<p style="top:707.4pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron intake in neurodegenerative processes, all in</span></p>
<p style="top:472.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">animal models. All 5 abstracts described adverse effects</span></p>
<p style="top:485.5pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of elevated iron intake on brain outcomes.</span></p>
<p style="top:516.5pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Assessment of risk of bias in the included studies</span></p>
<p style="top:540.7pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Assessments of preclinical studies are presented in</span></p>
<p style="top:553.1pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Tables 2</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> and</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> 3</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">. Assessments of clinical studies are pre-</span></p>
<p style="top:565.7pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">sented in</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> Tables 6</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> and</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> 7</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">.</span></p>
<p style="top:596.8pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Preclinical studies of the effect of high iron intake on</span></p>
<p style="top:608.8pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">behavior, brain aging, or neurodegeneration in</span></p>
<p style="top:620.8pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">neonates or adults</span></p>
<p style="top:644.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Fifteen studies used a mouse model and 19 a rat</span></p>
<p style="top:657.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">model. Five of the studies assessed the effect of ele-</span></p>
<p style="top:669.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">vated iron intake in genetic models of adult-onset neu-</span></p>
<p style="top:682.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">rodegenerative disease,</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">55</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">56</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">59</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">64</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">66</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">while the remainder</span></p>
<p style="top:694.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">studied aging or neurodegenerative processes in wild-</span></p>
<p style="top:707.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">type animals. All studies assessed the effect of elevated</span></p>
<p style="top:44.6pt;left:66.0pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 4</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> Human nutrition studies assessing the association between iron intake and brain outcomes</span></p>
<p style="top:58.2pt;left:66.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Reference</span></p>
<p style="top:58.2pt;left:142.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Study design</span></p>
<p style="top:58.2pt;left:232.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Population</span></p>
<p style="top:58.2pt;left:316.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Evaluation of dietary iron and</span></p>
<p style="top:68.2pt;left:350.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">outcomes</span></p>
<p style="top:58.2pt;left:460.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Main findings</span></p>
<p style="top:83.5pt;left:66.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Anderson et al.</span></p>
<p style="top:93.4pt;left:74.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(1999)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">72</span></sup></p>
<p style="top:83.5pt;left:140.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Case&#x2013;control</span></p>
<p style="top:83.5pt;left:197.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">103 newly diagnosed PD</span></p>
<p style="top:93.4pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">patients and 156 controls;</span></p>
<p style="top:103.5pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">WA, USA</span></p>
<p style="top:83.5pt;left:313.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">In-person interview about diet,</span></p>
<p style="top:93.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">covering most of adult life.</span></p>
<p style="top:103.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Risk of PD</span></p>
<p style="top:83.5pt;left:429.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron intake was not related</span></p>
<p style="top:93.4pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">to increased PD risk</span></p>
<p style="top:113.4pt;left:66.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Powers et al.</span></p>
<p style="top:123.5pt;left:74.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2003)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">71</span></sup></p>
<p style="top:113.4pt;left:140.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Case&#x2013;control</span></p>
<p style="top:113.4pt;left:197.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">250 newly diagnosed PD</span></p>
<p style="top:123.5pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">patients and 388 age- and</span></p>
<p style="top:133.5pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">sex-matched controls; WA,</span></p>
<p style="top:143.4pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">USA</span></p>
<p style="top:113.4pt;left:313.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">In-person interview about diet,</span></p>
<p style="top:123.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">covering most of adult life.</span></p>
<p style="top:133.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">OR for risk of development</span></p>
<p style="top:143.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">of PD for each quartile of</span></p>
<p style="top:153.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">dietary factor</span></p>
<p style="top:113.4pt;left:429.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Subjects in highest quartile</span></p>
<p style="top:123.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">of iron intake had in-</span></p>
<p style="top:133.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">creased risk of PD com-</span></p>
<p style="top:143.4pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">pared with those in lowest</span></p>
<p style="top:153.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">quartile (OR 1.7)</span></p>
<p style="top:163.4pt;left:66.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Powers et al.</span></p>
<p style="top:173.4pt;left:74.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2009)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">70</span></sup></p>
<p style="top:163.4pt;left:140.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Case&#x2013;control</span></p>
<p style="top:163.4pt;left:197.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">420 patients (median age 69 y)</span></p>
<p style="top:173.4pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and 560 age-, sex-, and</span></p>
<p style="top:183.5pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">ethnicity-matched controls</span></p>
<p style="top:193.4pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(median age, 71 y); USA</span></p>
<p style="top:163.4pt;left:313.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">In-person interview about diet,</span></p>
<p style="top:173.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">covering most of adult life.</span></p>
<p style="top:183.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Logistic regression used to</span></p>
<p style="top:193.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">determine OR for the devel-</span></p>
<p style="top:203.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">opment of PD for each level</span></p>
<p style="top:213.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">of dietary factor</span></p>
<p style="top:163.4pt;left:429.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Men in highest quartile of</span></p>
<p style="top:173.4pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron intake had increased</span></p>
<p style="top:183.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">risk of PD compared with</span></p>
<p style="top:193.4pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">those in lowest quartile</span></p>
<p style="top:203.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(OR 1.82)</span></p>
<p style="top:223.4pt;left:66.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Logroscino et al.</span></p>
<p style="top:233.5pt;left:74.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2008)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">69</span></sup></p>
<p style="top:223.4pt;left:140.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cohort</span></p>
<p style="top:223.4pt;left:197.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">47 406 men and 46 947</span></p>
<p style="top:233.5pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">women, all health</span></p>
<p style="top:243.4pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">professionals; USA</span></p>
<p style="top:223.4pt;left:313.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">FFQ every 4 y of study.</span></p>
<p style="top:233.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Outcome of PD as</span></p>
<p style="top:243.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">determined by neurologist</span></p>
<p style="top:223.4pt;left:429.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Increased intake of nonheme</span></p>
<p style="top:233.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron but not total iron is a</span></p>
<p style="top:243.4pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">risk for PD (relative</span></p>
<p style="top:253.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">risk</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xbc;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> 1.27 and 1.1,</span></p>
<p style="top:263.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">respectively)</span></p>
<p style="top:273.4pt;left:66.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Hernandez Mdel</span></p>
<p style="top:283.5pt;left:74.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">et al. (2015)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">68</span></sup></p>
<p style="top:273.4pt;left:140.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cohort</span></p>
<p style="top:273.4pt;left:197.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">1063 healthy, older,</span></p>
<p style="top:283.5pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">community-dwelling men</span></p>
<p style="top:293.4pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and women, mean age 73 y;</span></p>
<p style="top:303.5pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">UK</span></p>
<p style="top:273.4pt;left:313.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Self-reported food question-</span></p>
<p style="top:283.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">naire validated in older</span></p>
<p style="top:293.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">adults. Brain iron deposits</span></p>
<p style="top:303.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">determined by MRI in brain-</span></p>
<p style="top:313.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">stem, white matter, thala-</span></p>
<p style="top:323.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mus, basal ganglia, and</span></p>
<p style="top:333.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cortex. Blood iron markers</span></p>
<p style="top:343.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">ferritin and transferrin</span></p>
<p style="top:353.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">determined</span></p>
<p style="top:273.4pt;left:429.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Iron intake did not correlate</span></p>
<p style="top:283.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">with blood or brain iron</span></p>
<p style="top:293.4pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">measurements. Brain iron</span></p>
<p style="top:303.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">deposits did not correlate</span></p>
<p style="top:313.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">with blood iron</span></p>
<p style="top:323.4pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">measurements</span></p>
<p style="top:363.5pt;left:66.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Hagemeier et al.</span></p>
<p style="top:373.4pt;left:74.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2015)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">67</span></sup></p>
<p style="top:363.5pt;left:140.5pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cohort</span></p>
<p style="top:363.5pt;left:197.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">190 healthy men and women,</span></p>
<p style="top:373.4pt;left:204.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mean age 43 y, USA</span></p>
<p style="top:363.5pt;left:313.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Historic (3 y) nutritional</span></p>
<p style="top:373.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">questionnaire assessing</span></p>
<p style="top:383.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">consumption of iron, cal-</span></p>
<p style="top:393.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cium, vegetables, dairy,</span></p>
<p style="top:403.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and red meat. Brain iron</span></p>
<p style="top:413.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">determined by MRI in basal</span></p>
<p style="top:423.4pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">ganglia, thalamus, and</span></p>
<p style="top:433.5pt;left:321.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">substantia nigra</span></p>
<p style="top:363.5pt;left:429.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Trend toward increased brain</span></p>
<p style="top:373.4pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron with iron supplemen-</span></p>
<p style="top:383.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tation (</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xbc;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> 0.075). Effects</span></p>
<p style="top:393.5pt;left:437.8pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">were dependent on sex</span></p>
<p style="top:444.1pt;left:66.0pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">Abbreviations</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">: FFQ, food frequency questionnaire; MRI, magnetic resonance imaging; OR, odds ratio; PD, Parkinson disease.</span></p>
<p style="top:737.1pt;left:60.0pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:116.1pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:737.1pt;left:524.9pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">463</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:478.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neonatal iron intake. Levels of daily iron supplementa-</span></p>
<p style="top:491.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tion ranged from 2.5 to 120 mg/kg over a period of 3</span></p>
<p style="top:503.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">to 8 days. All studies except one</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">45</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">provided evidence</span></p>
<p style="top:516.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of adverse effects of increased neonatal iron intake on</span></p>
<p style="top:528.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neurologic outcomes. Many of the studies assessed be-</span></p>
<p style="top:541.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">havioral outcomes only. Sixteen studies evaluated mo-</span></p>
<p style="top:553.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tor outcomes such as open-field and/or rota-rod</span></p>
<p style="top:566.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">endurance. Of these, 13 found altered motor behav-</span></p>
<p style="top:578.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iors,</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">41</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">43</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">46</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">52</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">57</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">60</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">62</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and 3 did not.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">33</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">45</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">66</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Results</span></p>
<p style="top:591.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">from memory-based tests such as novel object recogni-</span></p>
<p style="top:603.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tion and/or radial-arm maze were presented in 13</span></p>
<p style="top:616.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">studies.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">33</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">35</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">37</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">40</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">42</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">44</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">46</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">48</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">50</span></sup></p>
<p style="top:628.6pt;left:74.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Brain regional biochemical analyses in the 34 pre-</span></p>
<p style="top:641.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">clinical studies most frequently investigated oxidative</span></p>
<p style="top:653.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">stress, neurochemical markers, or iron levels. Markers</span></p>
<p style="top:666.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of brain oxidative stress, including malondialdehyde</span></p>
<p style="top:678.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and protein carbonyls, were increased in 9 stud-</span></p>
<p style="top:691.1pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ies</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">34</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">49</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">55</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">58</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">63</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">65</span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">; the 1 study that assessed glutathione</span></p>
<p style="top:703.6pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">levels found no change.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">66</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Six studies assessed the effects</span></p>
<p style="top:478.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of neonatal iron intake on brain neurochemistry out-</span></p>
<p style="top:491.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">comes. Three of these studies reported decreased striatal</span></p>
<p style="top:503.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">dopamine in adult animals,</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">53</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">57</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">63</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">while 2 found no ef-</span></p>
<p style="top:516.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">fect on dopamine.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">60</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">62</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">One study demonstrated de-</span></p>
<p style="top:528.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">creased</span></p>
<p style="top:528.6pt;left:345.8pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">striatal</span></p>
<p style="top:528.6pt;left:382.2pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">acetylcholinesterase</span></p>
<p style="top:528.6pt;left:470.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">activity,</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">44</span></sup></p>
<p style="top:528.6pt;left:518.6pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and</span></p>
<p style="top:541.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">another found no effect on striatal serotonin.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">57</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Ten</span></p>
<p style="top:553.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">studies reported increased brain iron after neonatal</span></p>
<p style="top:566.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">supplementation.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">41</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">42</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">46</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">52</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">54</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">56</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">60</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">63</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Iron levels were ele-</span></p>
<p style="top:578.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">vated in the substantia nigra in 3 of 3 studies, in the</span></p>
<p style="top:591.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">basal ganglia in 6 of 7 studies, and in the cerebral cortex</span></p>
<p style="top:603.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">in 1 of 8 studies. Two studies found no effect of neona-</span></p>
<p style="top:616.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tal iron supplementation on iron levels in the striatum</span></p>
<p style="top:628.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and cortex.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">55</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">66</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Six studies used quantitative pathology</span></p>
<p style="top:641.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">to evaluate morphometric changes in the brain; these</span></p>
<p style="top:653.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">demonstrated significantly decreased neuronal numbers</span></p>
<p style="top:666.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">or neuronal cell body atrophy in specific brain re-</span></p>
<p style="top:678.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">gions.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">55</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">56</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">63</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">66</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Overall, significant adverse effects of</span></p>
<p style="top:691.1pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neonatal iron intake on morphologic or biochemical</span></p>
<p style="top:703.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">outcomes in specific brain regions were found in the</span></p>
<p style="top:44.6pt;left:62.0pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 5</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> Human studies assessing the association between peripheral iron status and brain outcomes</span></p>
<p style="top:58.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Reference</span></p>
<p style="top:58.2pt;left:143.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Study type</span></p>
<p style="top:58.2pt;left:231.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Population</span></p>
<p style="top:58.2pt;left:314.4pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Peripheral iron measures and</span></p>
<p style="top:68.2pt;left:335.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">brain outcome(s)</span></p>
<p style="top:58.2pt;left:456.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Main findings</span></p>
<p style="top:83.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Gao et al. (2008)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">79</span></sup></p>
<p style="top:83.5pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cross-sectional</span></p>
<p style="top:83.5pt;left:195.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">2000 men and women,</span><span style="font-family:AdvP4C4E51,serif;font-size:9.0pt"> &gt;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">65 y,</span></p>
<p style="top:93.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">rural areas; China</span></p>
<p style="top:83.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Plasma iron</span></p>
<p style="top:93.4pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cognitive assessment</span></p>
<p style="top:83.5pt;left:425.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Plasma iron was not corre-</span></p>
<p style="top:93.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">lated with cognitive scores</span></p>
<p style="top:103.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Lam et al. (2008)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">80</span></sup></p>
<p style="top:103.5pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cross-sectional</span></p>
<p style="top:103.5pt;left:195.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">1451 men and women, all</span></p>
<p style="top:113.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">ambulatory, mean age 75 y;</span></p>
<p style="top:123.5pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">USA</span></p>
<p style="top:103.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Plasma iron</span></p>
<p style="top:113.4pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cognitive assessment</span></p>
<p style="top:103.5pt;left:425.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Low and high (men) or high</span></p>
<p style="top:113.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(women) plasma iron asso-</span></p>
<p style="top:123.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">ciated with poorer perfor-</span></p>
<p style="top:133.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mance in a battery of</span></p>
<p style="top:143.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cognitive tests</span></p>
<p style="top:153.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Milward et al.</span></p>
<p style="top:163.4pt;left:70.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2010)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">77</span></sup></p>
<p style="top:153.5pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cohort</span></p>
<p style="top:153.5pt;left:195.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">800 community-dwelling</span></p>
<p style="top:163.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">adults,</span><span style="font-family:AdvP4C4E51,serif;font-size:9.0pt"> &gt;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">60 y; Australia</span></p>
<p style="top:153.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Serum iron, transferrin satura-</span></p>
<p style="top:163.4pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tion, and ferritin measured</span></p>
<p style="top:173.4pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">twice, 9 y apart</span></p>
<p style="top:183.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cognitive assessment in year 9</span></p>
<p style="top:153.5pt;left:425.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No relationships found</span></p>
<p style="top:163.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">between iron measures</span></p>
<p style="top:173.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and cognitive scores</span></p>
<p style="top:193.4pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Schiepers et al.</span></p>
<p style="top:203.5pt;left:70.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2010)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">78</span></sup></p>
<p style="top:193.4pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cohort</span></p>
<p style="top:193.4pt;left:195.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">818 adults, 50&#x2013;70 y (mean</span></p>
<p style="top:203.5pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">age 60 y); Netherlands</span></p>
<p style="top:193.4pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Total serum iron, total iron-</span></p>
<p style="top:203.5pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">binding capacity, transferrin</span></p>
<p style="top:213.4pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">saturation, and ferritin</span></p>
<p style="top:223.4pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cognitive assessment</span></p>
<p style="top:233.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Measurements taken at base-</span></p>
<p style="top:243.4pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">line and 3 y</span></p>
<p style="top:193.4pt;left:425.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Peripheral iron measures</span></p>
<p style="top:203.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">were not associated with</span></p>
<p style="top:213.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cognitive outcomes</span></p>
<p style="top:253.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Umur et al.</span></p>
<p style="top:263.5pt;left:70.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2011)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">75</span></sup></p>
<p style="top:253.5pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cross-sectional</span></p>
<p style="top:253.5pt;left:195.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">87 nursing home residents,</span></p>
<p style="top:263.5pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvP4C4E51,serif;font-size:9.0pt">&gt;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">65 y, both sexes, no</span></p>
<p style="top:273.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">neurologic diagnoses;</span></p>
<p style="top:283.5pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Turkey</span></p>
<p style="top:253.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Serum iron, transferrin satura-</span></p>
<p style="top:263.5pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">tion, and ferritin</span></p>
<p style="top:273.4pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Mini-mental status</span></p>
<p style="top:283.5pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">examination</span></p>
<p style="top:253.5pt;left:425.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Mild CI was associated with</span></p>
<p style="top:263.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">significantly higher serum</span></p>
<p style="top:273.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron (98%), ferritin (58%),</span></p>
<p style="top:283.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">and transferrin saturation</span></p>
<p style="top:293.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(107%)</span></p>
<p style="top:303.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Mueller et al.</span></p>
<p style="top:313.5pt;left:70.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2012)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">76</span></sup></p>
<p style="top:303.5pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Case&#x2013;control</span></p>
<p style="top:303.5pt;left:195.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">19 controls, 11 cases of stable</span></p>
<p style="top:313.5pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mild CI, 7 cases of progres-</span></p>
<p style="top:323.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">sive CI, and 19 cases of early</span></p>
<p style="top:333.5pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">dementia; mean age</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">78 y;</span></p>
<p style="top:343.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">USA</span></p>
<p style="top:303.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Serum copper and nonheme</span></p>
<p style="top:313.5pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">iron</span></p>
<p style="top:323.4pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cognitive testing every 6 mo</span></p>
<p style="top:333.5pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">for 5 y</span></p>
<p style="top:303.5pt;left:425.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Ratio of serum copper to</span></p>
<p style="top:313.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">nonheme iron increased</span></p>
<p style="top:323.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">during the progression</span></p>
<p style="top:333.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">from mild CI to Alzheimer</span></p>
<p style="top:343.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">disease. No change in</span></p>
<p style="top:353.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">nonheme iron</span></p>
<p style="top:363.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Andreeva et al.</span></p>
<p style="top:373.4pt;left:70.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2013)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">74</span></sup></p>
<p style="top:363.5pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cohort</span></p>
<p style="top:363.5pt;left:195.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">4959 men and women,</span></p>
<p style="top:373.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">35&#x2013;60 y; France</span></p>
<p style="top:363.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Hemoglobin determined in</span></p>
<p style="top:373.4pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">year 1; serum ferritin deter-</span></p>
<p style="top:383.5pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mined in years 1 and 6</span></p>
<p style="top:393.4pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cognitive outcomes evaluated</span></p>
<p style="top:403.4pt;left:316.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">at year 13</span></p>
<p style="top:363.5pt;left:425.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Lower serum ferritin was as-</span></p>
<p style="top:373.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">sociated with better out-</span></p>
<p style="top:383.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">comes of some cognitive</span></p>
<p style="top:393.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">measures in pre- and peri-</span></p>
<p style="top:403.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">menopausal women</span></p>
<p style="top:413.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Blasco et al.</span></p>
<p style="top:423.4pt;left:70.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2014)</span><sup><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">73</span></sup></p>
<p style="top:413.5pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Cross-sectional</span></p>
<p style="top:413.5pt;left:195.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">23 obese and 20 nonobese</span></p>
<p style="top:423.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">individuals, both sexes,</span></p>
<p style="top:433.5pt;left:203.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">mean age</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xfffd;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">49 y; Spain</span></p>
<p style="top:413.5pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Regional liver and brain iron</span></p>
<p style="top:423.4pt;left:318.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">measured by MRI R2*</span></p>
<p style="top:433.5pt;left:318.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">relaxation</span></p>
<p style="top:413.5pt;left:425.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Obese individuals had signifi-</span></p>
<p style="top:423.4pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cantly increased regional</span></p>
<p style="top:433.5pt;left:433.9pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">liver and brain iron load</span></p>
<p style="top:444.1pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">Abbreviations</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">: CI, cognitive impairment; MRI, magnetic resonance imaging.</span></p>
<p style="top:737.1pt;left:56.0pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">464</span></p>
<p style="top:737.1pt;left:413.2pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:469.4pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:663.6pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">substantia nigra (11 of 11 studies), the basal ganglia</span></p>
<p style="top:676.1pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">(16 of 18 studies), the hippocampus (11 of 12 studies),</span></p>
<p style="top:688.6pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and the cerebral cortex (6 of 13 studies). Two studies,</span></p>
<p style="top:701.1pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">in addition to assessing the effects of increased iron</span></p>
<p style="top:663.6pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">intake in neonates, also evaluated the effect of elevated</span></p>
<p style="top:676.1pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron intake in adult life; no effects in young adult or</span></p>
<p style="top:688.6pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">aged wild-type and Huntington disease mice were</span></p>
<p style="top:701.1pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">found.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">55</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">66</span></sup></p>
<img style="position:absolute;transform:matrix(.63954839,0,-0,.63951137,-63.42334,-155.76929)" src="data:image/jpeg;base64,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">
<p style="top:634.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">Figure 1</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.0pt"> Flow diagram of the literature search process.</span></p>
<p style="top:737.1pt;left:60.0pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:116.1pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:737.1pt;left:524.9pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">465</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:44.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Human studies assessing the correlation between iron</span></p>
<p style="top:56.6pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">nutrition or iron status markers and brain outcomes</span></p>
<p style="top:80.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Fourteen studies fulfilled the inclusion criteria in assess-</span></p>
<p style="top:93.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ing the potential correlation between iron nutrition or</span></p>
<p style="top:105.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">peripheral markers of iron nutrition and brain-related</span></p>
<p style="top:118.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">outcomes. Six studies had the primary purpose of exam-</span></p>
<p style="top:130.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ining the association between estimates of iron intake</span></p>
<p style="top:143.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and brain iron accumulation or risk of Parkinson dis-</span></p>
<p style="top:155.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ease.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">67</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">72</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Of these, 2 cohort studies looked for associa-</span></p>
<p style="top:168.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tions between iron intake and brain iron deposits. One</span></p>
<p style="top:180.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">was a large study in the United Kingdom that failed to</span></p>
<p style="top:193.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">find a correlation between recent iron intake and mag-</span></p>
<p style="top:205.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">netic resonance imaging (MRI) measures of brain iron</span></p>
<p style="top:218.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">deposition in healthy older individuals.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">68</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Another</span></p>
<p style="top:230.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">smaller study in the United States in middle-aged indi-</span></p>
<p style="top:243.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">viduals demonstrated a trend (</span><span style="font-family:AdvP3FCEB7,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xbc;</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> 0.075) toward in-</span></p>
<p style="top:255.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">creased</span></p>
<p style="top:255.7pt;left:349.2pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">MRI-measured</span></p>
<p style="top:255.7pt;left:423.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">brain</span></p>
<p style="top:255.7pt;left:457.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron</span></p>
<p style="top:255.7pt;left:486.4pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">with</span></p>
<p style="top:255.7pt;left:516.8pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron</span></p>
<p style="top:268.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">supplementation.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">67</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Four studies investigated possible</span></p>
<p style="top:280.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">associations between iron intake and Parkinson dis-</span></p>
<p style="top:293.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ease.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">69</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">72</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Three of these had a case&#x2013;control design and</span></p>
<p style="top:305.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">recruited study subjects from the state of Washington,</span></p>
<p style="top:318.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">USA. The initial smaller study did not find an associa-</span></p>
<p style="top:330.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tion between iron intake over most of adult life and the</span></p>
<p style="top:343.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">risk of Parkinson disease.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">72</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Two subsequent larger stud-</span></p>
<p style="top:355.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ies provided some evidence of an association between</span></p>
<p style="top:368.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">increased iron intake and risk of Parkinson disease.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">70</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">71</span></sup></p>
<p style="top:380.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The fourth study had a cohort design and was very large</span></p>
<p style="top:393.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">(94 353 subjects).</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">69</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The authors concluded that in-</span></p>
<p style="top:405.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">creased nonheme iron intake is a risk factor for</span></p>
<p style="top:418.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Parkinson disease, especially when ascorbate deficiency</span></p>
<p style="top:430.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">is present.</span></p>
<p style="top:443.2pt;left:324.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Eight studies had the primary purpose of determin-</span></p>
<p style="top:455.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ing the presence of associations between peripheral iron</span></p>
<p style="top:468.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">status and cognitive or other brain outcomes.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">73</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">80</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Four</span></p>
<p style="top:480.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of these had a cross-sectional design.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">73</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">75</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">79</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">80</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Three of</span></p>
<p style="top:493.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">these reported significant associations of iron levels</span></p>
<p style="top:505.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">with brain outcomes.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">73</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">75</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">80</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">One large study of 1451</span></p>
<p style="top:518.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">older individuals in the United States reported that high</span></p>
<p style="top:530.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">plasma iron levels correlated with poorer cognitive out-</span></p>
<p style="top:543.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">comes in both men and women.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">80</span></sup></p>
<p style="top:555.7pt;left:324.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">A much smaller study of 87 nursing home residents</span></p>
<p style="top:568.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">in Turkey reported that high serum iron, ferritin, and</span></p>
<p style="top:580.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">transferrin saturation were correlated with mild cogni-</span></p>
<p style="top:593.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tive impairment.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">75</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Another small Spanish study of 23</span></p>
<p style="top:605.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">obese and 20 nonobese middle-aged individuals found</span></p>
<p style="top:618.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">that MRI-measured brain and liver iron was elevated in</span></p>
<p style="top:630.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">obese individuals.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">73</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">One study of 2000 elderly individ-</span></p>
<p style="top:643.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">uals from rural areas of China reported no correlation</span></p>
<p style="top:655.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">between plasma iron and cognitive scores.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">79</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Three stud-</span></p>
<p style="top:668.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ies used a cohort design.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">74</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">77</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">78</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">A study of 800 older</span></p>
<p style="top:680.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">adults in Australia found no correlation between serum</span></p>
<p style="top:693.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron, transferrin saturation, or ferritin levels and cogni-</span></p>
<p style="top:705.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tive outcomes.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">77</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">One French study of 4959 middle-aged</span></p>
<p style="top:701.9pt;left:53.6pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 6</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> Risk-of-bias assessment for human studies assessing associations between iron nutrition and brain outcomes</span></p>
<p style="top:702.3pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Reference</span></p>
<p style="top:603.8pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was the research</span></p>
<p style="top:605.6pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">question focused?</span></p>
<p style="top:536.7pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Were appropriate</span></p>
<p style="top:532.6pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">methods used?</span></p>
<p style="top:469.5pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was case or</span></p>
<p style="top:460.4pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">cohort</span></p>
<p style="top:469.5pt;left:87.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">recruitment</span></p>
<p style="top:469.5pt;left:97.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">acceptable?</span></p>
<p style="top:422.4pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was control</span></p>
<p style="top:422.3pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">recruitment</span></p>
<p style="top:422.3pt;left:87.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">acceptable?</span></p>
<p style="top:367.3pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Did iron intake</span></p>
<p style="top:375.1pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">estimates minimize</span></p>
<p style="top:350.3pt;left:87.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">bias?</span></p>
<p style="top:301.8pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Were outcomes</span></p>
<p style="top:296.6pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">measured to</span></p>
<p style="top:300.4pt;left:87.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">minimize bias?</span></p>
<p style="top:241.3pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Were confounding</span></p>
<p style="top:220.6pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">factors</span></p>
<p style="top:234.7pt;left:87.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">accounted for?</span></p>
<p style="top:170.5pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was subject</span></p>
<p style="top:166.5pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">follow-up</span></p>
<p style="top:167.9pt;left:87.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">complete?</span></p>
<p style="top:122.9pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Are the key</span></p>
<p style="top:114.4pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">results</span></p>
<p style="top:117.0pt;left:87.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">precise?</span></p>
<p style="top:70.2pt;left:67.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Are the</span></p>
<p style="top:68.7pt;left:77.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">results</span></p>
<p style="top:76.9pt;left:87.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">believable?</span></p>
<p style="top:702.3pt;left:111.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Anderson et al (1999)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">72</span></p>
<p style="top:579.3pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span></p>
<p style="top:512.3pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:455.1pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:407.9pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:347.6pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:280.0pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:215.0pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:155.2pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:108.1pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span></p>
<p style="top:66.4pt;left:112.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:702.3pt;left:121.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Powers et al (2003)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">71</span></p>
<p style="top:579.3pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span></p>
<p style="top:512.3pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:455.1pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:407.9pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:347.6pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:280.0pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:215.0pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:155.2pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:109.0pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:66.4pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:702.3pt;left:131.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Powers et al (2009)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">70</span></p>
<p style="top:579.3pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span></p>
<p style="top:512.3pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:455.1pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:407.9pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:347.6pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:280.0pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:215.0pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:155.2pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:109.0pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:66.4pt;left:132.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:702.3pt;left:141.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Logroscino et al (2008)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">69</span></p>
<p style="top:580.3pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:512.3pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:455.1pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:407.2pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:347.6pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:280.7pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:215.0pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:155.8pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:109.0pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:66.4pt;left:142.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:702.3pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Hernandez Mdel et al</span></p>
<p style="top:694.3pt;left:161.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">(2015)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">68</span></p>
<p style="top:580.3pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:512.7pt;left:151.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span></p>
<p style="top:455.1pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:407.2pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:347.6pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:280.7pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:215.0pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:155.8pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:108.1pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span></p>
<p style="top:66.4pt;left:152.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:702.3pt;left:171.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Hagemeier et al (2015)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">67</span></p>
<p style="top:580.3pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:512.3pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:455.1pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:407.2pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:347.6pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:280.7pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:215.0pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:155.8pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:109.0pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:66.4pt;left:172.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:702.3pt;left:183.3pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">Abbreviation</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">: NA, not applicable for study.</span></p>
<p style="top:704.4pt;left:191.9pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">The timing and the period of dietary intake analysis were not optimal. Unclear inclusion and exclusion criteria.</span></p>
<p style="top:737.1pt;left:56.0pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">466</span></p>
<p style="top:737.1pt;left:413.2pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:469.4pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:44.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">individuals reported associations between lower serum</span></p>
<p style="top:57.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ferritin and better cognitive outcomes, but only in pre-</span></p>
<p style="top:69.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and perimenopausal women.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">74</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">A Netherlands-based</span></p>
<p style="top:82.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">study of 818 middle-aged and older individuals found</span></p>
<p style="top:94.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">no evidence of an association between peripheral mea-</span></p>
<p style="top:107.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">sures of iron and cognitive performance.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">78</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Finally, a</span></p>
<p style="top:119.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">case&#x2013;control study of 37 older individuals in the United</span></p>
<p style="top:132.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">States found that serum nonheme iron did not increase</span></p>
<p style="top:144.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">during the progression from mild cognitive impairment</span></p>
<p style="top:157.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">to Alzheimer disease.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">76</span></sup></p>
<p style="top:183.5pt;left:399.0pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">DISCUSSION</span></p>
<p style="top:207.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">This systematic review examined evidence from animal</span></p>
<p style="top:219.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and human studies that investigated whether high iron</span></p>
<p style="top:232.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">intake or markers of iron status correlated with cogni-</span></p>
<p style="top:244.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tive decline or the onset/progression of neurodegenera-</span></p>
<p style="top:257.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tive disease. Almost all the animal studies assessed the</span></p>
<p style="top:269.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">effects of elevated iron intake in neonatal life on out-</span></p>
<p style="top:282.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">comes in early to late adult life. These studies over-</span></p>
<p style="top:294.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">whelmingly</span></p>
<p style="top:294.9pt;left:366.6pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">demonstrated</span></p>
<p style="top:294.9pt;left:430.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">adverse</span></p>
<p style="top:294.9pt;left:469.6pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">effects</span></p>
<p style="top:294.9pt;left:503.4pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of</span></p>
<p style="top:294.9pt;left:519.8pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">high</span></p>
<p style="top:307.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neonatal iron intake on diverse behavioral, brain mor-</span></p>
<p style="top:319.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">phologic, and biochemical outcomes. In striking con-</span></p>
<p style="top:332.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">trast, none of the human studies assessed the effects of</span></p>
<p style="top:344.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">high iron intake in early life on adult cognitive or brain</span></p>
<p style="top:357.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron outcomes.</span></p>
<p style="top:369.9pt;left:328.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">There is substantial evidence that early-life envi-</span></p>
<p style="top:382.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ronmental factors, including nutrition, influence brain</span></p>
<p style="top:394.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">development, which may then impact susceptibility to</span></p>
<p style="top:407.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">brain aging or neurodegenerative processes in later</span></p>
<p style="top:419.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">life.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">81</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Since brain iron accumulation is linked to aging</span></p>
<p style="top:432.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and neurodegenerative processes, it is important to un-</span></p>
<p style="top:444.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">derstand the effects of high iron intake at various life</span></p>
<p style="top:457.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">stages on the human brain. Preclinical studies evaluated</span></p>
<p style="top:469.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the effects of neonatal iron intake on outcomes related</span></p>
<p style="top:482.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">to behavior and aging processes (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 2</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">) and on neu-</span></p>
<p style="top:494.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">rodegenerative processes in wild-type and genetically</span></p>
<p style="top:507.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">modified animals (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 3</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">). None of the studies fulfilled</span></p>
<p style="top:519.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">all the methodological criteria for quality. Although the</span></p>
<p style="top:532.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">strength of many studies was weakened by underreport-</span></p>
<p style="top:544.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ing of methodological details, all but 1 preclinical</span></p>
<p style="top:557.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">study</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">45</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">(</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 2</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">) provided evidence that elevated iron</span></p>
<p style="top:569.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">intake in early life adversely affects cognition in adult</span></p>
<p style="top:582.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">rodents. Although outcomes in early adult life were</span></p>
<p style="top:594.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">studied most frequently, iron supplementation did in-</span></p>
<p style="top:607.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">crease brain regional iron levels, a marker of brain ag-</span></p>
<p style="top:619.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ing.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">15</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">16</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Studies focused on neurodegenerative disease</span></p>
<p style="top:632.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">outcomes (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 3</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">) also provide evidence that neonatal</span></p>
<p style="top:644.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron supplementation promotes age-dependent progres-</span></p>
<p style="top:657.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">sive neurodegeneration in the substantia nigra, the</span></p>
<p style="top:669.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">main area of brain degeneration in Parkinson dis-</span></p>
<p style="top:682.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ease.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">53</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">57</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">63</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">65</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Preclinical studies investigating interac-</span></p>
<p style="top:694.9pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tions</span></p>
<p style="top:694.9pt;left:339.5pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">between</span></p>
<p style="top:694.9pt;left:381.3pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neonatal</span></p>
<p style="top:694.9pt;left:424.5pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron</span></p>
<p style="top:694.9pt;left:450.1pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">nutrition</span></p>
<p style="top:694.9pt;left:495.3pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and</span></p>
<p style="top:694.9pt;left:519.1pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">gene</span></p>
<p style="top:707.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">mutations causing neurodegeneration showed evidence</span></p>
<p style="top:703.0pt;left:57.6pt;line-height:9.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.5pt">Table 7</span><span style="font-family:AdvOT35387326.B,serif;font-size:9.5pt"> Risk-of-bias assessment for human studies assessing associations between peripheral iron status and brain outcomes</span></p>
<p style="top:703.4pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Reference</span></p>
<p style="top:613.6pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was the</span></p>
<p style="top:614.2pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">research</span></p>
<p style="top:614.8pt;left:91.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">question</span></p>
<p style="top:614.9pt;left:101.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">focused?</span></p>
<p style="top:565.5pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Were</span></p>
<p style="top:576.7pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">appropriate</span></p>
<p style="top:571.7pt;left:91.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">methods</span></p>
<p style="top:566.4pt;left:101.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">used?</span></p>
<p style="top:528.4pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was case or cohort</span></p>
<p style="top:516.0pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">recruitment</span></p>
<p style="top:516.0pt;left:91.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">acceptable?</span></p>
<p style="top:455.2pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was control</span></p>
<p style="top:455.1pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">recruitment</span></p>
<p style="top:455.1pt;left:91.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">acceptable?</span></p>
<p style="top:406.5pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was iron status</span></p>
<p style="top:402.1pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">estimated to</span></p>
<p style="top:396.1pt;left:91.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">minimize</span></p>
<p style="top:388.8pt;left:101.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">bias?</span></p>
<p style="top:346.0pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Were outcomes</span></p>
<p style="top:340.7pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">measured to</span></p>
<p style="top:344.5pt;left:91.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">minimize bias?</span></p>
<p style="top:278.0pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Were confounding</span></p>
<p style="top:284.0pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">factors accounted for?</span></p>
<p style="top:199.7pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Was subject</span></p>
<p style="top:195.7pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">follow-up</span></p>
<p style="top:197.1pt;left:91.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">complete?</span></p>
<p style="top:144.2pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Are the key</span></p>
<p style="top:150.6pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">results precise?</span></p>
<p style="top:90.3pt;left:71.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Are the results</span></p>
<p style="top:84.6pt;left:81.3pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">believable?</span></p>
<p style="top:703.4pt;left:115.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Gao et al (2008)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">79</span></p>
<p style="top:605.7pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:562.4pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:501.7pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:440.0pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:386.1pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:324.9pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:251.8pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:184.4pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:130.4pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:74.2pt;left:116.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:703.4pt;left:125.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Lam et al (2008)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">80</span></p>
<p style="top:605.7pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:562.4pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:499.9pt;left:125.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span></p>
<p style="top:440.1pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:386.1pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:324.9pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:251.8pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:184.4pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:130.4pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:74.2pt;left:126.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:703.4pt;left:135.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Milward et al (2010)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">77</span></p>
<p style="top:605.7pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:560.9pt;left:135.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span></p>
<p style="top:501.7pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:440.0pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:386.1pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:324.9pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:251.8pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:185.0pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:130.4pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:74.2pt;left:136.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:703.4pt;left:145.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Schiepers et al (2010)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">78</span></p>
<p style="top:605.7pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:562.4pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:501.7pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:440.0pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:386.1pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:324.9pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:251.8pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:185.0pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:130.4pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:74.2pt;left:146.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:703.4pt;left:155.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Umur et al (2011)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">75</span></p>
<p style="top:605.7pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:562.4pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:501.7pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:440.0pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:386.1pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:324.9pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:251.8pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:184.4pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:130.4pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:74.2pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:703.4pt;left:165.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Mueller et al (2012)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">76</span></p>
<p style="top:605.7pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:562.4pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:501.7pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:440.7pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:386.1pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:324.9pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:250.8pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span></p>
<p style="top:185.0pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:130.4pt;left:166.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:74.5pt;left:165.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span></p>
<p style="top:703.4pt;left:175.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Andreeva et al (2013)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">74</span></p>
<p style="top:605.7pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:560.9pt;left:175.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">U</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span></p>
<p style="top:501.7pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:440.0pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:386.1pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:324.9pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:251.8pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:185.0pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:130.4pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:74.2pt;left:176.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:703.4pt;left:185.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Blasco et al (2014)</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt;color:#2e3092">73</span></p>
<p style="top:605.7pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:562.4pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:501.7pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:440.0pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:386.1pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:324.9pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:250.8pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span></p>
<p style="top:184.4pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">NA</span></p>
<p style="top:130.4pt;left:186.6pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Yes</span></p>
<p style="top:74.9pt;left:185.2pt;line-height:9.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">No</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span></p>
<p style="top:703.4pt;left:197.3pt;line-height:9.0pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:9.0pt">Abbreviations</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">: NA, not applicable for study; U, unclear inclusion and exclusion criteria.</span></p>
<p style="top:705.5pt;left:205.9pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">a</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Inclusion and exclusion criteria unclear.</span></p>
<p style="top:705.5pt;left:215.9pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">b</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Lack of controls to measure cognition at baseline.</span></p>
<p style="top:705.5pt;left:225.9pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">c</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Small group sizes (n</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xbc;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> 18&#x2013;19).</span></p>
<p style="top:705.5pt;left:235.9pt;line-height:6.4pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:6.4pt">d</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt">Small group sizes (n</span><span style="font-family:AdvP4C4E74,serif;font-size:9.0pt"> &#xbc;</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:9.0pt"> 20&#x2013;23).</span></p>
<p style="top:737.1pt;left:60.0pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:116.1pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:737.1pt;left:524.9pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">467</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:44.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of synergism between iron intake and genetic disease</span></p>
<p style="top:57.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">factors, although the number of studies was small.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">55</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">64</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">66</span></sup></p>
<p style="top:69.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">These findings suggest that individuals with gene muta-</span></p>
<p style="top:82.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tions</span></p>
<p style="top:82.4pt;left:84.2pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">causing</span></p>
<p style="top:82.4pt;left:123.1pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">protein-misfolding</span></p>
<p style="top:82.4pt;left:207.8pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">neurodegenerative</span></p>
<p style="top:94.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">diseases may have increased susceptibility to the adverse</span></p>
<p style="top:107.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">effects of high iron intake in early life.</span></p>
<p style="top:119.9pt;left:74.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Exactly how the effects of neonatal iron intake in</span></p>
<p style="top:132.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">mice translate to humans is unclear. The form and the</span></p>
<p style="top:144.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">dose of iron supplementation are key factors affecting</span></p>
<p style="top:157.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the interpretation of preclinical studies. Soluble ferrous</span></p>
<p style="top:169.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">succinate and insoluble iron carbonyl were used in the</span></p>
<p style="top:182.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">included preclinical studies; both forms are used for hu-</span></p>
<p style="top:194.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">man supplementation. There was considerable variation</span></p>
<p style="top:207.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">in the daily dose of iron used in the neonatal iron sup-</span></p>
<p style="top:219.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">plementation studies. The highest dose of 120 mg/kg</span></p>
<p style="top:232.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">was used only with iron carbonyl, which has less bio-</span></p>
<p style="top:244.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">availability than ferrous salts.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">82</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">This highest level of</span></p>
<p style="top:257.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">supplementation in mice is estimated to result in an ap-</span></p>
<p style="top:269.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">proximate 40-fold increase over the iron present in nat-</span></p>
<p style="top:282.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ural milk. Human infants fed iron-fortified formula</span></p>
<p style="top:294.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">have an iron intake level of up to 14 mg/d, which is also</span></p>
<p style="top:307.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">about</span></p>
<p style="top:307.4pt;left:87.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">40-fold</span></p>
<p style="top:307.4pt;left:125.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the</span></p>
<p style="top:307.4pt;left:147.5pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">intake</span></p>
<p style="top:307.4pt;left:181.4pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">level</span></p>
<p style="top:307.4pt;left:208.5pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of</span></p>
<p style="top:307.4pt;left:225.5pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">breastfed</span></p>
<p style="top:307.4pt;left:271.2pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">in-</span></p>
<p style="top:319.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">fants.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">41</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">63</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">83</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">&#x2013;</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">85</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Therefore, when translating iron dose on</span></p>
<p style="top:332.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">a milligram-per-kilogram (mg/kg) basis from rodents</span></p>
<p style="top:344.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">to humans, the highest levels of supplementation used</span></p>
<p style="top:357.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">in the preclinical studies appear relevant to human</span></p>
<p style="top:369.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">nutrition.</span></p>
<p style="top:382.4pt;left:74.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">All of the included human studies assessed the ef-</span></p>
<p style="top:394.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">fect of adult-life iron intake or iron status on brain out-</span></p>
<p style="top:407.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">comes. These studies varied considerably in design,</span></p>
<p style="top:419.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">size, and outcomes measures. Study qualities were gen-</span></p>
<p style="top:432.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">erally good (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Tables 6</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> and</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> 7</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">). However, not surprisingly,</span></p>
<p style="top:444.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">results varied widely (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Tables 4</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> and</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092"> 5</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">). Several of the hu-</span></p>
<p style="top:457.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">man studies used Parkinson disease as their outcome,</span></p>
<p style="top:469.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">which is not surprising, given the evidence of an associ-</span></p>
<p style="top:482.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ation between substantia nigra iron accumulation and</span></p>
<p style="top:494.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Parkinson disease.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">86</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The most complete iron nutrition</span></p>
<p style="top:507.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">study, based on the large number of subjects, the pro-</span></p>
<p style="top:519.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">spective study design, and the repeated food question-</span></p>
<p style="top:532.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">naire analysis performed every 4 years, was that of</span></p>
<p style="top:544.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Logroscino et al.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">69</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">(</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 4</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">). These authors concluded</span></p>
<p style="top:557.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">that increased nonheme iron intake is a risk for</span></p>
<p style="top:569.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Parkinson disease, especially when concurrent ascor-</span></p>
<p style="top:582.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">bate deficiency is present. The literature searches con-</span></p>
<p style="top:594.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">ducted for the present review, however, did not identify</span></p>
<p style="top:607.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">any preclinical studies evaluating the effect of high iron</span></p>
<p style="top:619.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">intake in adult life on Parkinson disease outcomes in</span></p>
<p style="top:632.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">animal models. Preclinical studies that use varied out-</span></p>
<p style="top:644.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">comes would inform the need for additional human</span></p>
<p style="top:657.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">adult iron-nutrition studies assessing the risk for</span></p>
<p style="top:669.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Parkinson disease development. Most studies evaluating</span></p>
<p style="top:682.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the effects of peripheral iron status found evidence to</span></p>
<p style="top:694.9pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">support an association with poorer outcomes (</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt;color:#2e3092">Table 5</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">).</span></p>
<p style="top:707.4pt;left:56.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">A weakness of the studies investigating blood iron</span></p>
<p style="top:44.9pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">status is that comprehensive measures of peripheral</span></p>
<p style="top:57.4pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron status were frequently not used. Furthermore, al-</span></p>
<p style="top:69.9pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">though some studies accounted for confounding fac-</span></p>
<p style="top:82.4pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tors, many did not account for the presence of</span></p>
<p style="top:94.9pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">inflammatory disease, which influences iron status.</span><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">87</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt">,</span></sup><sup><span style="font-family:AdvP48A5E4,serif;font-size:7.1pt;color:#2e3092">88</span></sup></p>
<p style="top:126.9pt;left:393.0pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">CONCLUSION</span></p>
<p style="top:150.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">When the results of animal studies are combined, there</span></p>
<p style="top:163.3pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">is moderately strong evidence that nutritionally relevant</span></p>
<p style="top:175.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">levels of high iron intake during early postnatal life</span></p>
<p style="top:188.3pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">have adverse effects on the adult brain. Future preclini-</span></p>
<p style="top:200.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">cal studies could focus on improving the understanding</span></p>
<p style="top:213.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">of how high neonatal iron intake impacts the brain in</span></p>
<p style="top:225.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">adult life. Thus far, human studies of the effects of high</span></p>
<p style="top:238.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">iron intake on cognition and risk of disease do not</span></p>
<p style="top:250.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">strengthen these preclinical findings because they have</span></p>
<p style="top:263.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">investigated the effects of iron intake only in adult life.</span></p>
<p style="top:275.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">There are significant challenges, such as cost and time,</span></p>
<p style="top:288.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">when conducting prospective studies to examine the ef-</span></p>
<p style="top:300.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">fects of early-life high iron intake on adult cognition</span></p>
<p style="top:313.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and brain aging processes. Retrospective studies are also</span></p>
<p style="top:325.7pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">challenging because of the potential for recall bias.</span></p>
<p style="top:338.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Nevertheless, the need for human studies in this area</span></p>
<p style="top:350.8pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">is supported by the preclinical findings reported in</span></p>
<p style="top:363.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the literature. Human studies should assess factors</span></p>
<p style="top:375.8pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">besides nutrition that influence iron status, such as</span></p>
<p style="top:388.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">physiologic blood loss, gene polymorphisms, and the</span></p>
<p style="top:400.8pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">presence of inflammatory disease processes to better</span></p>
<p style="top:413.2pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">determine the role of iron nutrition on the outcomes</span></p>
<p style="top:425.8pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">investigated.</span></p>
<p style="top:457.8pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Acknowledgments</span></p>
<p style="top:482.0pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The authors thank Paul Troxell at the Society for</span></p>
<p style="top:494.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Neuroscience for access to the abstract database and</span></p>
<p style="top:507.0pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">Jenny Garcia, University of Wyoming Coe Library, for</span></p>
<p style="top:519.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">guidance with the database searches.</span></p>
<p style="top:544.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP3FCEB7,serif;font-size:10.0pt">Author contributions.</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> K.L.B. and E.M. completed an ini-</span></p>
<p style="top:557.0pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">tial literature search and analysis which defined the</span></p>
<p style="top:569.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">focus of the review. J.H.F. and S.A. designed the final</span></p>
<p style="top:582.0pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">searches, screened the papers for inclusion, extracted</span></p>
<p style="top:594.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">and summarized data, and completed methodological</span></p>
<p style="top:607.0pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">assessments. All authors contributed to writing and</span></p>
<p style="top:619.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">reviewing the manuscript and read and approved the</span></p>
<p style="top:632.0pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">submitted version.</span></p>
<p style="top:657.5pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP3FCEB7,serif;font-size:10.0pt">Funding/support.</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt"> This work was supported by a grant from</span></p>
<p style="top:669.9pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">the National Institutes of Health (NIH RO1 NS079450).</span></p>
<p style="top:694.9pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP3FCEB7,serif;font-size:10.0pt">Declaration of interest</span><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">. The authors have no relevant</span></p>
<p style="top:707.4pt;left:306.9pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">interests to declare.</span></p>
<p style="top:737.1pt;left:56.0pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">468</span></p>
<p style="top:737.1pt;left:413.2pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:469.4pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:44.6pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">Supporting Information</span></p>
<p style="top:68.7pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">The following Supporting Information is available</span></p>
<p style="top:81.2pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">through the online version of this article at the publish-</span></p>
<p style="top:93.7pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP48A5E4,serif;font-size:10.0pt">er&#x2019;s website.</span></p>
<p style="top:106.2pt;left:78.0pt;line-height:10.0pt"><span style="font-family:AdvP3FCEB7,serif;font-size:10.0pt">Appendix S1</span><span style="font-family:AdvP3FA08E,serif;font-size:10.0pt"> Online search strategies for preclini-</span></p>
<p style="top:118.7pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP3FA08E,serif;font-size:10.0pt">cal and clinical studies</span></p>
<p style="top:131.2pt;left:78.0pt;line-height:10.0pt"><span style="font-family:AdvP3FCEB7,serif;font-size:10.0pt">Table S1</span><span style="font-family:AdvP3FA08E,serif;font-size:10.0pt"> Preferred reporting items for systematic</span></p>
<p style="top:143.7pt;left:60.0pt;line-height:10.0pt"><span style="font-family:AdvP3FA08E,serif;font-size:10.0pt">reviews or meta-analyses: the PRISMA statement</span></p>
<p style="top:171.1pt;left:147.5pt;line-height:10.0pt"><span style="font-family:AdvOT35387326.B,serif;font-size:10.0pt">REFERENCES</span></p>
<p style="top:190.5pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">1.</span></p>
<p style="top:190.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Wu LL, Zhang L, Shao J, et al. Effect of perinatal iron deficiency on myelination</span></p>
<p style="top:198.9pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">and associated behaviors in rat pups. Behav Brain Res. 2008;188:263&#x2013;270.</span></p>
<p style="top:207.5pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2.</span></p>
<p style="top:207.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Brunette KE, Tran PV, Wobken JD, et al. Gestational and neonatal iron deficiency</span></p>
<p style="top:216.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">alters apical dendrite structure of CA1 pyramidal neurons in adult rat hippocam-</span></p>
<p style="top:224.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">pus. Dev Neurosci. 2010;32:238&#x2013;248.</span></p>
<p style="top:233.0pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">3.</span></p>
<p style="top:233.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Daubner SC, Le T, Wang S. Tyrosine hydroxylase and regulation of dopamine syn-</span></p>
<p style="top:241.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">thesis. Arch Biochem Biophys. 2011;508:1&#x2013;12.</span></p>
<p style="top:250.0pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">4.</span></p>
<p style="top:250.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Holmes-Hampton GP, Chakrabarti M, Cockrell AL, et al. Changing iron content of</span></p>
<p style="top:258.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">the mouse brain during development. Metallomics. 2012;4:761&#x2013;770.</span></p>
<p style="top:267.0pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">5.</span></p>
<p style="top:267.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Chen JH, Shahnavas S, Singh N, et al. Stable iron isotope tracing reveals significant</span></p>
<p style="top:275.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">brain iron uptake in adult rats. Metallomics. 2013;5:167&#x2013;173.</span></p>
<p style="top:284.0pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">6.</span></p>
<p style="top:284.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Baltussen R, Knai C, Sharan M. Iron fortification and iron supplementation are</span></p>
<p style="top:292.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">cost-effective interventions to reduce iron deficiency in four subregions of the</span></p>
<p style="top:301.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">world. J Nutr. 2004;134:2678&#x2013;2684.</span></p>
<p style="top:309.5pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">7.</span></p>
<p style="top:309.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in</span></p>
<p style="top:317.9pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">young women. Am J Clin Nutr. 2007;85:778&#x2013;787.</span></p>
<p style="top:326.5pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">8.</span></p>
<p style="top:326.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Scott SP, Murray-Kolb LE. Iron status is associated with performance on executive</span></p>
<p style="top:335.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">functioning tasks in nonanemic young women. J Nutr. 2016;146:30&#x2013;37.</span></p>
<p style="top:343.5pt;left:63.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">9.</span></p>
<p style="top:343.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Lozoff B, Beard J, Connor J, et al. Long-lasting neural and behavioral effects of iron</span></p>
<p style="top:352.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">deficiency in infancy. Nutr Rev. 2006;64(5 pt 2):S34&#x2013;S43; discussion S72&#x2013;S91.</span></p>
<p style="top:360.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">10.</span></p>
<p style="top:360.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Bailey RL, Gahche JJ, Lentino CV, et al. Dietary supplement use in the United</span></p>
<p style="top:369.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">States, 2003&#x2013;2006. J Nutr. 2011;141:261&#x2013;266.</span></p>
<p style="top:377.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">11.</span></p>
<p style="top:377.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Hardiman O, Doherty CP, eds. Neurodegenerative Disorders: A Clinical Guide.</span></p>
<p style="top:386.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">London, UK: Springer; 2011.</span></p>
<p style="top:394.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">12.</span></p>
<p style="top:394.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Thal DR, Del Tredici K, Braak H. Neurodegeneration in normal brain aging and</span></p>
<p style="top:403.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">disease. Sci Aging Knowledge Environ. 2004;2004:pe26. doi:10.1126/sageke.</span></p>
<p style="top:411.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2004.23.pe26.</span></p>
<p style="top:420.0pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">13.</span></p>
<p style="top:420.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal</span></p>
<p style="top:428.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">intranuclear</span></p>
<p style="top:428.5pt;left:114.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">inclusions</span></p>
<p style="top:428.5pt;left:147.7pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">and</span></p>
<p style="top:428.5pt;left:165.8pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">dystrophic</span></p>
<p style="top:428.5pt;left:201.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">neurites</span></p>
<p style="top:428.5pt;left:230.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">in</span></p>
<p style="top:428.5pt;left:243.3pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">brain.</span></p>
<p style="top:428.5pt;left:266.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Science.</span></p>
<p style="top:437.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">1997;277:1990&#x2013;1993.</span></p>
<p style="top:445.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">14.</span></p>
<p style="top:445.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Guerrero EN, Wang H, Mitra J, et al. TDP-43/FUS in motor neuron disease: com-</span></p>
<p style="top:454.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">plexity and challenges. Prog Neurobiol. 2016;145&#x2013;146:78&#x2013;97.</span></p>
<p style="top:462.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">15.</span></p>
<p style="top:462.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human</span></p>
<p style="top:471.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">brain. J Neurochem. 1958;3:41&#x2013;51.</span></p>
<p style="top:479.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">16.</span></p>
<p style="top:479.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Ghadery C, Pirpamer L, Hofer E, et al. R2* mapping for brain iron: associations</span></p>
<p style="top:488.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">with cognition in normal aging. Neurobiol Aging. 2015;36:925&#x2013;932.</span></p>
<p style="top:496.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">17.</span></p>
<p style="top:496.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Raven EP, Lu PH, Tishler TA, et al. Increased iron levels and decreased tissue integ-</span></p>
<p style="top:505.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">rity in hippocampus of Alzheimer&#x2019;s disease detected in vivo with magnetic reso-</span></p>
<p style="top:513.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">nance imaging. J Alzheimers Dis. 2013;37:127&#x2013;136.</span></p>
<p style="top:522.0pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">18.</span></p>
<p style="top:522.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">He N, Ling H, Ding B, et al. Region-specific disturbed iron distribution in early idio-</span></p>
<p style="top:530.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">pathic Parkinson&#x2019;s disease measured by quantitative susceptibility mapping. Hum</span></p>
<p style="top:539.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Brain Mapp. 2015;36:4407&#x2013;4420.</span></p>
<p style="top:547.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">19.</span></p>
<p style="top:547.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Rosas HD, Chen YI, Doros G, et al. Alterations in brain transition metals in Huntington</span></p>
<p style="top:556.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">disease: an evolving and intricate story. Arch Neurol. 2012;69:887&#x2013;893.</span></p>
<p style="top:564.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">20.</span></p>
<p style="top:564.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Ignjatovic A, Stevic Z, Lavrnic S, et al. Brain iron MRI: a biomarker for amyotrophic</span></p>
<p style="top:573.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">lateral sclerosis. J Magn Reson Imaging. 2013;38:1472&#x2013;1479.</span></p>
<p style="top:581.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">21.</span></p>
<p style="top:581.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Elder GA, Gama Sosa MA, De Gasperi R. Transgenic mouse models of Alzheimer&#x2019;s</span></p>
<p style="top:590.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">disease. Mt Sinai J Med. 2010;77:69&#x2013;81.</span></p>
<p style="top:598.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">22.</span></p>
<p style="top:598.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Duty S, Jenner P. Animal models of Parkinson&#x2019;s disease: a source of novel treat-</span></p>
<p style="top:607.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">ments and clues to the cause of the disease. Br J Pharmacol. 2011;164:1357&#x2013;1391.</span></p>
<p style="top:615.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">23.</span></p>
<p style="top:615.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Philips T, Rothstein JD. Rodent models of amyotrophic lateral sclerosis. Curr</span></p>
<p style="top:624.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Protoc Pharmacol. 2015;69:5.67.1&#x2013;5.67.21.</span></p>
<p style="top:632.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">24.</span></p>
<p style="top:632.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Ferrante RJ. Mouse models of Huntington&#x2019;s disease and methodological consider-</span></p>
<p style="top:641.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">ations for therapeutic trials. Biochim Biophys Acta. 2009;1792:506&#x2013;520.</span></p>
<p style="top:649.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">25.</span></p>
<p style="top:649.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Li K, Reichmann H. Role of iron in neurodegenerative diseases. J Neural Transm</span></p>
<p style="top:658.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">(Vienna). 2016;123:389&#x2013;399.</span></p>
<p style="top:666.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">26.</span></p>
<p style="top:666.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Nunez MT, Urrutia P, Mena N, et al. Iron toxicity in neurodegeneration. Biometals.</span></p>
<p style="top:675.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2012;25:761&#x2013;776.</span></p>
<p style="top:683.5pt;left:60.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">27.</span></p>
<p style="top:683.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for</span></p>
<p style="top:692.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese,</span></p>
<p style="top:700.5pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Molybdenum, Nickel, Silicon, Vanadium and Zinc. Washington, DC: National</span></p>
<p style="top:709.0pt;left:75.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Academy Press; 2001.</span></p>
<p style="top:45.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">28.</span></p>
<p style="top:45.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fleming DJ, Jacques PF, Tucker KL, et al. Iron status of the free-living, elderly</span></p>
<p style="top:53.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Framingham Heart Study cohort: an iron-replete population with a high preva-</span></p>
<p style="top:62.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">lence of elevated iron stores. Am J Clin Nutr. 2001;73:638&#x2013;646.</span></p>
<p style="top:70.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">29.</span></p>
<p style="top:70.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic re-</span></p>
<p style="top:79.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">views and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.</span></p>
<p style="top:87.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">doi:10.1371/journal.pmed.1000097.</span></p>
<p style="top:96.3pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">30.</span></p>
<p style="top:96.3pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Institute for Laboratory Animal Research, National Research Council. Guidance for</span></p>
<p style="top:104.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">the Description of Animal Research in Animal Research in Scientific Publications.</span></p>
<p style="top:113.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Washington, DC: National Academies Press; 2011.</span></p>
<p style="top:121.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">31.</span></p>
<p style="top:121.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other</span></p>
<p style="top:130.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">methodological criteria of published animal studies: a systematic review. Environ</span></p>
<p style="top:138.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Health Perspect. 2013;121:985&#x2013;992.</span></p>
<p style="top:147.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">32.</span></p>
<p style="top:147.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment</span></p>
<p style="top:155.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">tools for preclinical and clinical studies, systematic review and meta-</span></p>
<p style="top:164.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">analysis, and clinical practice guideline: a systematic review. J Evid Based</span></p>
<p style="top:172.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Med. 2015;8:2&#x2013;10.</span></p>
<p style="top:181.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">33.</span></p>
<p style="top:181.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Lavich IC, de Freitas BS, Kist LW, et al. Sulforaphane rescues memory dysfunction</span></p>
<p style="top:189.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">and synaptic and mitochondrial alterations induced by brain iron accumulation.</span></p>
<p style="top:198.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Neuroscience. 2015;301:542&#x2013;552.</span></p>
<p style="top:206.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">34.</span></p>
<p style="top:206.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Budni P, de Lima MN, Polydoro M, et al. Antioxidant effects of selegiline in oxida-</span></p>
<p style="top:215.3pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">tive stress induced by iron neonatal treatment in rats. Neurochem Res.</span></p>
<p style="top:223.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2007;32:965&#x2013;972.</span></p>
<p style="top:232.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">35.</span></p>
<p style="top:232.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">de Lima MN, Laranja DC, Caldana F, et al. Selegiline protects against recognition</span></p>
<p style="top:240.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">memory impairment induced by neonatal iron treatment. Exp Neurol.</span></p>
<p style="top:249.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2005;196:177&#x2013;183.</span></p>
<p style="top:257.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">36.</span></p>
<p style="top:257.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">de Lima MN, Presti-Torres J, Caldana F, et al. Desferoxamine reverses neonatal</span></p>
<p style="top:266.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">iron-induced recognition memory impairment in rats. Eur J Pharmacol.</span></p>
<p style="top:274.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2007;570:111&#x2013;114.</span></p>
<p style="top:283.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">37.</span></p>
<p style="top:283.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">de Lima MN, Presti-Torres J, Garcia VA, et al. Amelioration of recognition memory</span></p>
<p style="top:291.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">impairment associated with iron loading or aging by the type 4-specific phospho-</span></p>
<p style="top:300.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">diesterase inhibitor rolipram in rats. Neuropharmacology. 2008;55:788&#x2013;792.</span></p>
<p style="top:308.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">38.</span></p>
<p style="top:308.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Dornelles AS, Garcia VA, de Lima MN, et al. mRNA expression of proteins involved</span></p>
<p style="top:317.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">in iron homeostasis in brain regions is altered by age and by iron overloading in</span></p>
<p style="top:325.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">the neonatal period. Neurochem Res. 2010;35:564&#x2013;571.</span></p>
<p style="top:334.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">39.</span></p>
<p style="top:334.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fernandez LL, de Lima MN, Scalco F, et al. Early post-natal iron administration in-</span></p>
<p style="top:342.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">duces astroglial response in the brain of adult and aged rats. Neurotox Res.</span></p>
<p style="top:351.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2011;20:193&#x2013;199.</span></p>
<p style="top:359.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">40.</span></p>
<p style="top:359.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Figueiredo LS, de Freitas BS, Garcia VA, et al. Iron loading selectively increases hip-</span></p>
<p style="top:368.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">pocampal levels of ubiquitinated proteins and impairs hippocampus-dependent</span></p>
<p style="top:376.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">memory. Mol Neurobiol. 2016;53:6228&#x2013;6239.</span></p>
<p style="top:385.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">41.</span></p>
<p style="top:385.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fredriksson A, Schroder N, Eriksson P, et al. Neonatal iron exposure induces neuro-</span></p>
<p style="top:393.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">behavioural dysfunctions in adult mice. Toxicol Appl Pharmacol. 1999;159:25&#x2013;30.</span></p>
<p style="top:402.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">42.</span></p>
<p style="top:402.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fredriksson A, Schroder N, Eriksson P, et al. Maze learning and motor activity defi-</span></p>
<p style="top:410.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">cits in adult mice induced by iron exposure during a critical postnatal period.</span></p>
<p style="top:419.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Brain Res Dev Brain Res. 2000;119:65&#x2013;74.</span></p>
<p style="top:427.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">43.</span></p>
<p style="top:427.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Isaac G, Fredriksson A, Danielsson R, et al. Brain lipid composition in postnatal</span></p>
<p style="top:436.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">iron-induced motor behavior alterations following chronic neuroleptic administra-</span></p>
<p style="top:444.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">tion in mice. FEBS J. 2006;273:2232&#x2013;2243.</span></p>
<p style="top:453.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">44.</span></p>
<p style="top:453.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Perez VP, de Lima MN, da Silva RS, et al. Iron leads to memory impairment that is</span></p>
<p style="top:461.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">associated with a decrease in acetylcholinesterase pathways. Curr Neurovasc Res.</span></p>
<p style="top:470.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2010;7:15&#x2013;22.</span></p>
<p style="top:478.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">45.</span></p>
<p style="top:478.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Rech RL, de Lima MN, Dornelles A, et al. Reversal of age-associated memory im-</span></p>
<p style="top:487.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">pairment by rosuvastatin in rats. Exp Gerontol. 2010;45:351&#x2013;356.</span></p>
<p style="top:495.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">46.</span></p>
<p style="top:495.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Schroder N, Fredriksson A, Vianna MR, et al. Memory deficits in adult rats follow-</span></p>
<p style="top:504.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">ing postnatal iron administration. Behav Brain Res. 2001;124:77&#x2013;85.</span></p>
<p style="top:512.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">47.</span></p>
<p style="top:512.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">da Silva VK, de Freitas BS, da Silva Dornelles A, et al. Cannabidiol normalizes cas-</span></p>
<p style="top:521.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">pase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels</span></p>
<p style="top:529.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">in rats with brain iron overload: implications for neuroprotection. Mol Neurobiol.</span></p>
<p style="top:538.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2014;49:222&#x2013;233.</span></p>
<p style="top:546.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">48.</span></p>
<p style="top:546.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Silva PF, Garcia VA, Dornelles AS, et al. Memory impairment induced by brain iron</span></p>
<p style="top:555.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">overload is accompanied by reduced H3K9 acetylation and ameliorated by so-</span></p>
<p style="top:563.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">dium butyrate. Neuroscience. 2012;200:42&#x2013;49.</span></p>
<p style="top:572.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">49.</span></p>
<p style="top:572.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">de Lima MN, Polydoro M, Laranja DC, et al. Recognition memory impairment and</span></p>
<p style="top:580.8pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">brain oxidative stress induced by postnatal iron administration. Eur J Neurosci.</span></p>
<p style="top:589.3pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2005;21:2521&#x2013;2528.</span></p>
<p style="top:597.8pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">50.</span></p>
<p style="top:597.8pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fagherazzi EV, Garcia VA, Maurmann N, et al. Memory-rescuing effects of cannabi-</span></p>
<p style="top:606.3pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">diol in an animal model of cognitive impairment relevant to neurodegenerative</span></p>
<p style="top:614.8pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">disorders. Psychopharmacology (Berlin). 2012;219:1133&#x2013;1140.</span></p>
<p style="top:623.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">51.</span></p>
<p style="top:623.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Miwa CP, de Lima MN, Scalco F, et al. Neonatal iron treatment increases apoptotic</span></p>
<p style="top:631.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">markers in hippocampal and cortical areas of adult rats. Neurotox Res.</span></p>
<p style="top:640.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2011;19:527&#x2013;535.</span></p>
<p style="top:648.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">52.</span></p>
<p style="top:648.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fredriksson A, Schroder N, Archer T. Neurobehavioural deficits following postnatal</span></p>
<p style="top:657.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">iron overload: I spontaneous motor activity. Neurotox Res. 2003;5:53&#x2013;76.</span></p>
<p style="top:665.9pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">53.</span></p>
<p style="top:665.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Wang X, Wang M, Yang L, et al. Inhibition of Sirtuin 2 exerts neuroprotection in</span></p>
<p style="top:674.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">aging</span></p>
<p style="top:674.4pt;left:347.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">rats</span></p>
<p style="top:674.4pt;left:363.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">with</span></p>
<p style="top:674.4pt;left:381.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">increased</span></p>
<p style="top:674.4pt;left:412.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">neonatal</span></p>
<p style="top:674.4pt;left:441.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">iron</span></p>
<p style="top:674.4pt;left:457.7pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">intake.</span></p>
<p style="top:674.4pt;left:481.2pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Neural</span></p>
<p style="top:674.4pt;left:504.6pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Regen</span></p>
<p style="top:674.4pt;left:527.6pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Res.</span></p>
<p style="top:682.9pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2014;9:1917&#x2013;1922.</span></p>
<p style="top:691.4pt;left:310.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">54.</span></p>
<p style="top:691.4pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Archer T, Fredriksson A. Functional consequences of iron overload in cate-</span></p>
<p style="top:699.8pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">cholaminergic</span></p>
<p style="top:699.8pt;left:373.3pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">interactions:</span></p>
<p style="top:699.8pt;left:415.5pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">the</span></p>
<p style="top:699.8pt;left:432.3pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Youdim</span></p>
<p style="top:699.8pt;left:461.5pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">factor.</span></p>
<p style="top:699.8pt;left:486.8pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Neurochem</span></p>
<p style="top:699.8pt;left:526.8pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Res.</span></p>
<p style="top:708.3pt;left:326.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2007;32:1625&#x2013;1639.</span></p>
<p style="top:737.1pt;left:60.0pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:116.1pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:737.1pt;left:524.9pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">469</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>


<p style="top:45.4pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">55.</span></p>
<p style="top:45.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Berggren KL, Chen J, Fox J, et al. Neonatal iron supplementation potentiates oxi-</span></p>
<p style="top:53.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">dative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse</span></p>
<p style="top:62.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">model of Huntington&#x2019;s disease. Redox Biol. 2015;4:363&#x2013;374.</span></p>
<p style="top:70.9pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">56.</span></p>
<p style="top:70.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Billings JL, Hare DJ, Nurjono M, et al. Effects of neonatal iron feeding and chronic</span></p>
<p style="top:79.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">clioquinol administration on the parkinsonian human a53t transgenic mouse. ACS</span></p>
<p style="top:87.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Chem Neurosci. 2016;7:360&#x2013;366.</span></p>
<p style="top:96.3pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">57.</span></p>
<p style="top:96.3pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Chen H, Wang X, Wang M, et al. Behavioral and neurochemical deficits in aging</span></p>
<p style="top:104.8pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">rats with increased neonatal iron intake: Silibinin&#x2019;s neuroprotection by maintaining</span></p>
<p style="top:113.3pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">redox balance. Front Aging Neurosci. 2015;7:206. doi:10.3389/fnagi.2015.00206.</span></p>
<p style="top:121.8pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">58.</span></p>
<p style="top:121.8pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Dal-Pizzol F, Klamt F, Frota ML Jr, et al. Neonatal iron exposure induces oxidative</span></p>
<p style="top:130.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">stress in adult Wistar rat. Brain Res Dev Brain Res. 2001;130:109&#x2013;114.</span></p>
<p style="top:138.9pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">59.</span></p>
<p style="top:138.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fernandez LL, Carmona M, Portero-Otin M, et al. Effects of increased iron intake</span></p>
<p style="top:147.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">during the neonatal period on the brain of adult A</span><span style="font-family:AdvPSMP10,serif;font-size:7.0pt">b</span><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">PP/PS1 transgenic mice. J</span></p>
<p style="top:155.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Alzheimers Dis. 2010;19:1069&#x2013;1080.</span></p>
<p style="top:164.4pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">60.</span></p>
<p style="top:164.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fredriksson A, Archer T. Effect of postnatal iron administration on MPTP-induced</span></p>
<p style="top:172.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801</span></p>
<p style="top:181.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">co-administration. Behav Brain Res. 2003;139:31&#x2013;46.</span></p>
<p style="top:189.9pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">61.</span></p>
<p style="top:189.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fredriksson A, Archer T. Subchronic administration of haloperidol influences the func-</span></p>
<p style="top:198.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">tional deficits of postnatal iron administration in mice. Neurotox Res. 2006;9:305&#x2013;312.</span></p>
<p style="top:206.9pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">62.</span></p>
<p style="top:206.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Fredriksson A, Schroder N, Eriksson P, et al. Neonatal iron potentiates adult MPTP-</span></p>
<p style="top:215.3pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">induced neurodegenerative and functional deficits. Parkinsonism Relat Disord.</span></p>
<p style="top:223.8pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2001;7:97&#x2013;105.</span></p>
<p style="top:232.3pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">63.</span></p>
<p style="top:232.3pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Kaur D, Peng J, Chinta SJ, et al. Increased murine neonatal iron intake results in</span></p>
<p style="top:240.8pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Parkinson-like neurodegeneration with age. Neurobiol Aging. 2007;28:907&#x2013;913.</span></p>
<p style="top:249.4pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">64.</span></p>
<p style="top:249.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Peng J, Oo ML, Andersen JK. Synergistic effects of environmental risk factors and</span></p>
<p style="top:257.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">gene mutations in Parkinson&#x2019;s disease accelerate age-related neurodegeneration.</span></p>
<p style="top:266.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">J Neurochem. 2010;115:1363&#x2013;1373.</span></p>
<p style="top:274.9pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">65.</span></p>
<p style="top:274.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Peng J, Peng L, Stevenson FF, et al. Iron and paraquat as synergistic environmen-</span></p>
<p style="top:283.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">tal risk factors in sporadic Parkinson&#x2019;s disease accelerate age-related neurodegen-</span></p>
<p style="top:291.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">eration. J Neurosci. 2007;27:6914&#x2013;6922.</span></p>
<p style="top:300.4pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">66.</span></p>
<p style="top:300.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Berggren KL, Lu Z, Fox JA, et al. Neonatal iron supplementation induces striatal atro-</span></p>
<p style="top:308.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">phy in female YAC128 Huntington&#x2019;s disease nice. J Huntingtons Dis. 2016;5:53&#x2013;63.</span></p>
<p style="top:317.4pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">67.</span></p>
<p style="top:317.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Hagemeier J, Tong O, Dwyer MG, et al. Effects of diet on brain iron levels among</span></p>
<p style="top:325.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">healthy individuals: an MRI pilot study. Neurobiol Aging. 2015;36:1678&#x2013;1685.</span></p>
<p style="top:334.3pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">68.</span></p>
<p style="top:334.3pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Hernandez Mdel C, Allan J, Glatz A, et al. Exploratory analysis of dietary intake and</span></p>
<p style="top:342.8pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">brain iron accumulation detected using magnetic resonance imaging in older in-</span></p>
<p style="top:351.3pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">dividuals: the Lothian Birth Cohort 1936. J Nutr, Health Aging. 2015;19:64&#x2013;69.</span></p>
<p style="top:359.9pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">69.</span></p>
<p style="top:359.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Logroscino G, Gao X, Chen H, et al. Dietary iron intake and risk of Parkinson&#x2019;s dis-</span></p>
<p style="top:368.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">ease. Am J Epidemiol. 2008;168:1381&#x2013;1388.</span></p>
<p style="top:376.9pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">70.</span></p>
<p style="top:376.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Powers KM, Smith-Weller T, Franklin GM, et al. Dietary fats, cholesterol and iron as</span></p>
<p style="top:385.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">risk factors for Parkinson&#x2019;s disease. Parkinsonism Relat Disord. 2009;15:47&#x2013;52.</span></p>
<p style="top:393.9pt;left:56.0pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">71.</span></p>
<p style="top:393.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Powers KM, Smith-Weller T, Franklin GM, et al. Parkinson&#x2019;s disease risks associated</span></p>
<p style="top:402.4pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">with</span></p>
<p style="top:402.4pt;left:88.6pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">dietary</span></p>
<p style="top:402.4pt;left:112.3pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">iron,</span></p>
<p style="top:402.4pt;left:129.7pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">manganese,</span></p>
<p style="top:402.4pt;left:166.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">and</span></p>
<p style="top:402.4pt;left:182.6pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">other</span></p>
<p style="top:402.4pt;left:202.4pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">nutrient</span></p>
<p style="top:402.4pt;left:229.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">intakes.</span></p>
<p style="top:402.4pt;left:254.4pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Neurology.</span></p>
<p style="top:410.9pt;left:71.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2003;60:1761&#x2013;1766.</span></p>
<p style="top:45.4pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">72.</span></p>
<p style="top:45.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Anderson C, Checkoway H, Franklin GM, et al. Dietary factors in Parkinson&#x2019;s</span></p>
<p style="top:53.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">disease: the role of food groups and specific foods. Mov Disord.</span></p>
<p style="top:62.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">1999;14:21&#x2013;27.</span></p>
<p style="top:70.9pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">73.</span></p>
<p style="top:70.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Blasco G, Puig J, Daunis IEJ, et al. Brain iron overload, insulin resistance, and cogni-</span></p>
<p style="top:79.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">tive performance in obese subjects: a preliminary MRI case-control study.</span></p>
<p style="top:87.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Diabetes Care. 2014;37:3076&#x2013;3083.</span></p>
<p style="top:96.3pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">74.</span></p>
<p style="top:96.3pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Andreeva VA, Galan P, Arnaud J, et al. Midlife iron status is inversely associated</span></p>
<p style="top:104.8pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">with subsequent cognitive performance, particularly in perimenopausal women. J</span></p>
<p style="top:113.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Nutr. 2013;143:1974&#x2013;1981.</span></p>
<p style="top:121.9pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">75.</span></p>
<p style="top:121.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Umur EE, Oktenli C, Celik S, et al. Increased iron and oxidative stress are separately</span></p>
<p style="top:130.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">related to cognitive decline in elderly. Geriatr Gerontol Int. 2011;11:504&#x2013;509.</span></p>
<p style="top:138.9pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">76.</span></p>
<p style="top:138.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Mueller C, Schrag M, Crofton A, et al. Altered serum iron and copper homeostasis</span></p>
<p style="top:147.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">predicts cognitive decline in mild cognitive impairment. J Alzheimers Dis.</span></p>
<p style="top:155.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2012;29:341&#x2013;350.</span></p>
<p style="top:164.4pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">77.</span></p>
<p style="top:164.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Milward EA, Bruce DG, Knuiman MW, et al. A cross-sectional community study of</span></p>
<p style="top:172.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">serum iron measures and cognitive status in older adults. J Alzheimers Dis.</span></p>
<p style="top:181.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2010;20:617&#x2013;623.</span></p>
<p style="top:189.9pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">78.</span></p>
<p style="top:189.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Schiepers OJ, van Boxtel MP, de Groot RH, et al. Serum iron parameters, HFE</span></p>
<p style="top:198.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">C282Y genotype, and cognitive performance in older adults: results from the</span></p>
<p style="top:206.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">FACIT study. J Gerontol A Biol Sci Med Sci. 2010;65:1312&#x2013;1321.</span></p>
<p style="top:215.3pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">79.</span></p>
<p style="top:215.3pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Gao S, Jin Y, Unverzagt FW, et al. Trace element levels and cognitive function in</span></p>
<p style="top:223.8pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">rural elderly Chinese. J Gerontol A Biol Sci Med Sci. 2008;63:635&#x2013;641.</span></p>
<p style="top:232.4pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">80.</span></p>
<p style="top:232.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Lam PK, Kritz-Silverstein D, Barrett Connor E, et al. Plasma trace elements and cog-</span></p>
<p style="top:240.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">nitive function in older men and women: the Rancho Bernardo study. J Nutr</span></p>
<p style="top:249.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Health Aging. 2008;12:22&#x2013;27.</span></p>
<p style="top:257.9pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">81.</span></p>
<p style="top:257.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Modgil S, Lahiri DK, Sharma VL, et al. Role of early life exposure and environment</span></p>
<p style="top:266.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">on neurodegeneration: implications on brain disorders. Transl Neurodegener.</span></p>
<p style="top:274.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2014;3:9. doi:10.1186/2047-9158-3-9.</span></p>
<p style="top:283.4pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">82.</span></p>
<p style="top:283.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Devasthali SD, Gordeuk VR, Brittenham GM, et al. Bioavailability of carbonyl iron: a</span></p>
<p style="top:291.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">randomized, double-blind study. Eur J Haematol. 1991;46:272&#x2013;278.</span></p>
<p style="top:300.4pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">83.</span></p>
<p style="top:300.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Dewey KG, Finley DA, Lonnerdal B. Breast milk volume and composition during</span></p>
<p style="top:308.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">late lactation (7&#x2013;20 months). J Pediatr Gastroenterol Nutr. 1984;3:713&#x2013;720.</span></p>
<p style="top:317.4pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">84.</span></p>
<p style="top:317.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Dewey KG, Lonnerdal B. Milk and nutrient intake of breast-fed infants from 1 to 6</span></p>
<p style="top:325.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">months: relation to growth and fatness. J Pediatr Gastroenterol Nutr.</span></p>
<p style="top:334.3pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">1983;2:497&#x2013;506.</span></p>
<p style="top:342.9pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">85.</span></p>
<p style="top:342.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Lonnerdal B. Effects of milk and milk components on calcium, magnesium, and</span></p>
<p style="top:351.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">trace element absorption during infancy. Physiol Rev. 1997;77:643&#x2013;669.</span></p>
<p style="top:359.9pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">86.</span></p>
<p style="top:359.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Ayton S, Lei P. Nigral iron elevation is an invariable feature of Parkinson&#x2019;s disease</span></p>
<p style="top:368.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">and is a sufficient cause of neurodegeneration. Biomed Res Int. 2014;2014:581256.</span></p>
<p style="top:376.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">doi:10.1155/2014/581256.</span></p>
<p style="top:385.4pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">87.</span></p>
<p style="top:385.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: past, present and future.</span></p>
<p style="top:393.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Biochim Biophys Acta. 2010;1800:760&#x2013;769.</span></p>
<p style="top:402.4pt;left:306.9pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">88.</span></p>
<p style="top:402.4pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am.</span></p>
<p style="top:410.9pt;left:322.1pt;line-height:7.0pt"><span style="font-family:AdvOT5fcf1b24,serif;font-size:7.0pt">2014;28:671&#x2013;681.</span></p>
<p style="top:737.1pt;left:56.0pt;line-height:8.5pt"><span style="font-family:AdvOT35387326.B,serif;font-size:8.5pt">470</span></p>
<p style="top:737.1pt;left:413.2pt;line-height:8.5pt"><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt">Nutrition Reviews</span><sup><span style="font-family:AdvP80516,serif;font-size:4.4pt">V</span></sup></p>
<p style="top:738.6pt;left:469.4pt;line-height:3.3pt"><span style="font-family:AdvOT35387326.B,serif;font-size:3.3pt">R</span><span style="font-family:AdvOT5c7b8c86.I,serif;font-size:8.5pt"> Vol. 75(6):456&#x2013;470</span></p>
<p style="top:180.4pt;left:570.0pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt;color:#666666">Downloaded from https://academic.oup.com/nutritionreviews/article/75/6/456/3828105 by guest on 26 January 2023</span></p>

</div>
